This is a Validated Antibody Database (VAD) review about chicken CDH2, based on 268 published articles (read how Labome selects the articles), using CDH2 antibody in all methods. It is aimed to help Labome visitors find the most suited CDH2 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CDH2 synonym: cadherin-2

Knockout validation
Invitrogen
mouse monoclonal (CH-19)
  • western blot knockout validation; human; loading ...; fig 3a
  • immunohistochemistry - paraffin section; human; loading ...; fig 1a, 2g
Invitrogen CDH2 antibody (Thermo Fisher, MA1-91128) was used in western blot knockout validation on human samples (fig 3a) and in immunohistochemistry - paraffin section on human samples (fig 1a, 2g). J Immunother Cancer (2021) ncbi
Abcam
domestic rabbit polyclonal
  • immunohistochemistry knockout validation; mouse; 1:1000; loading ...; fig s3b
Abcam CDH2 antibody (Abcam, ab76057) was used in immunohistochemistry knockout validation on mouse samples at 1:1000 (fig s3b). Cells (2019) ncbi
BD Biosciences
mouse monoclonal (32/N-Cadherin)
  • immunohistochemistry knockout validation; mouse; loading ...; fig 2a, 2b
  • western blot knockout validation; mouse; loading ...; fig 2c
BD Biosciences CDH2 antibody (BD, 610921) was used in immunohistochemistry knockout validation on mouse samples (fig 2a, 2b) and in western blot knockout validation on mouse samples (fig 2c). Dev Biol (2017) ncbi
Invitrogen
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; mouse; 1:500; loading ...; fig 3
Invitrogen CDH2 antibody (ThermoFisher, 33-3900) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 3). Nat Commun (2021) ncbi
mouse monoclonal (CH-19)
  • western blot knockout validation; human; loading ...; fig 3a
  • immunohistochemistry - paraffin section; human; loading ...; fig 1a, 2g
Invitrogen CDH2 antibody (Thermo Fisher, MA1-91128) was used in western blot knockout validation on human samples (fig 3a) and in immunohistochemistry - paraffin section on human samples (fig 1a, 2g). J Immunother Cancer (2021) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry; human; 1:100; loading ...; tbl 2
Invitrogen CDH2 antibody (Thermo Fisher Scientific, 3B9) was used in immunohistochemistry on human samples at 1:100 (tbl 2). Mod Pathol (2020) ncbi
mouse monoclonal (3B9)
  • western blot; mouse; 1:500; loading ...; fig 4h
Invitrogen CDH2 antibody (Thermo, 33-3900) was used in western blot on mouse samples at 1:500 (fig 4h). elife (2020) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 6d
Invitrogen CDH2 antibody (ThermoFisher, 33-3900) was used in immunohistochemistry - frozen section on mouse samples (fig 6d). J Biol Chem (2019) ncbi
mouse monoclonal (3B9)
  • immunocytochemistry; mouse; 1:250; loading ...; fig 1a
Invitrogen CDH2 antibody (Thermo Fisher, 33-3900) was used in immunocytochemistry on mouse samples at 1:250 (fig 1a). J Cell Sci (2019) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry; mouse; 1:200; loading ...; fig 3a
In order to examine connexin40 and connexin43 expression in mouse models of hypoxia and sleep apnea, Invitrogen CDH2 antibody (Life Technologies, 33-3900) was used in immunohistochemistry on mouse samples at 1:200 (fig 3a). BMC Cell Biol (2017) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry; rat; loading ...; fig 7b
In order to describe a cardiovascular progenitor population derived during embryonic stem cell differentiation, Invitrogen CDH2 antibody (Invitrogen, 3B9) was used in immunohistochemistry on rat samples (fig 7b). Stem Cells Int (2016) ncbi
mouse monoclonal (3B9)
  • immunocytochemistry; mouse; loading ...; fig 3b
In order to show that decreased WNT/beta-catenin contributes to the pathophysiology of lamin A/C gene cardiomyopathy, Invitrogen CDH2 antibody (Invitrogen, 33-3900) was used in immunocytochemistry on mouse samples (fig 3b). Hum Mol Genet (2017) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry; mouse; loading ...
In order to discuss methods to generate induced cardiomyocytes in vitro and in vivo, Invitrogen CDH2 antibody (Thermo Fisher, 33-3900) was used in immunohistochemistry on mouse samples . Methods Mol Biol (2017) ncbi
mouse monoclonal (3B9)
  • immunocytochemistry; rat; 1:200; loading ...; fig 3a
  • western blot; rat; 1:200; loading ...; fig 3a
In order to explore how laminin2 in the basement membrane modulates the blood testis barrier dynamics during spermatogenesis, Invitrogen CDH2 antibody (ThermoFisher Scientific, 33-3900) was used in immunocytochemistry on rat samples at 1:200 (fig 3a) and in western blot on rat samples at 1:200 (fig 3a). FASEB J (2017) ncbi
mouse monoclonal (3B9)
  • western blot; human; loading ...; fig 4b
In order to investigate the role of Cx26 to cell mobility, Invitrogen CDH2 antibody (Thermo, 33-3900) was used in western blot on human samples (fig 4b). J Cell Sci (2016) ncbi
mouse monoclonal (3B9)
  • immunocytochemistry; human; loading ...; fig 3c
In order to show that apical polarization of the sodium, potassium-ATPase in retinal pigment epithelium cells depends on the expression of the beta2 subunit, Invitrogen CDH2 antibody (ZYMED, 333900) was used in immunocytochemistry on human samples (fig 3c). Front Physiol (2016) ncbi
mouse monoclonal (3B9)
  • immunocytochemistry; human; loading ...; fig 5c
  • western blot; human; loading ...; fig 5c
In order to investigate the alternative splicing of E-cadherin mRNA, Invitrogen CDH2 antibody (Zymed, 3-B9) was used in immunocytochemistry on human samples (fig 5c) and in western blot on human samples (fig 5c). J Cell Physiol (2017) ncbi
mouse monoclonal (3B9)
  • immunocytochemistry; rat; 1:100; loading ...; tbl 1
  • western blot; rat; 1:500; loading ...; tbl 1
In order to examine the organization of actin microfilaments in Sertoli cell at the blood testis barrier, Invitrogen CDH2 antibody (Invitrogen, 33-3900) was used in immunocytochemistry on rat samples at 1:100 (tbl 1) and in western blot on rat samples at 1:500 (tbl 1). Spermatogenesis (2016) ncbi
mouse monoclonal (CH-19)
  • western blot; mouse; loading ...; fig 1a
In order to explore how ST8SIA2-mediated polysialylation influences oligodendrocyte differentiation and schizophrenia, Invitrogen CDH2 antibody (Thermo Scientific, MA1-91128) was used in western blot on mouse samples (fig 1a). Glia (2017) ncbi
mouse monoclonal (3B9)
  • immunocytochemistry; rat; 1:100; fig 1
  • western blot; rat; 1:500; fig 1
In order to characterize overexpression of gap junction protein connexin 43 by rescue of perfluorooctanesulfonate (PFOS)-mediated sertoli cell injury, Invitrogen CDH2 antibody (Invitrogen, 33-3900) was used in immunocytochemistry on rat samples at 1:100 (fig 1) and in western blot on rat samples at 1:500 (fig 1). Sci Rep (2016) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry; human; loading ...
In order to identify signaling pathways that mediate the EGF-induced epithelial to mesenchymal transition, Invitrogen CDH2 antibody (Thermo Fisher, 33-3900) was used in immunohistochemistry on human samples . J Proteomics (2017) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - frozen section; rat; 1:100; fig 2
  • immunocytochemistry; rat; 1:100; fig 5
  • western blot; rat; 1:200; fig 5
In order to report that crumbs homolog 3 is an actin microfilament regulator, Invitrogen CDH2 antibody (Invitrogen, Life Technologies, 33-3900) was used in immunohistochemistry - frozen section on rat samples at 1:100 (fig 2), in immunocytochemistry on rat samples at 1:100 (fig 5) and in western blot on rat samples at 1:200 (fig 5). Sci Rep (2016) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - frozen section; mouse; 1:200; fig s3
In order to study induction of granulosa cell fate and defects and cancers in mouse adult ovary by amplification of R-spondin1 signaling, Invitrogen CDH2 antibody (Invitrogen, 33-3900) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (fig s3). Oncogene (2017) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; human; 1:50; fig 3
In order to determine mediation of differentiation and cisplatin chemotherapy resistance by biased expression of the FOXP3delta3 isoform in aggressive bladder cancer, Invitrogen CDH2 antibody (Invitrogen, 33-3900) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 3). Clin Cancer Res (2016) ncbi
mouse monoclonal (3B9)
  • immunoprecipitation; rat; 1:60; fig 2
  • immunocytochemistry; rat; 1:100; fig 1
  • western blot; rat; 1:200; fig 3
In order to determine regulation of ectoplasmic specialization dynamics via its effects on actin microfilaments in the testes of male rats by planar cell polarity (PCP) protein Vangl2, Invitrogen CDH2 antibody (Invitrogen, 33-3900) was used in immunoprecipitation on rat samples at 1:60 (fig 2), in immunocytochemistry on rat samples at 1:100 (fig 1) and in western blot on rat samples at 1:200 (fig 3). Endocrinology (2016) ncbi
mouse monoclonal (3B9)
  • immunocytochemistry; rat; 1:100; fig 1
In order to characterize disruption of the sertolic cell cytoskeleton by interleukin 1alpha and its affect on gap junctional communication, Invitrogen CDH2 antibody (Invitrogen, 33-3900) was used in immunocytochemistry on rat samples at 1:100 (fig 1). Cell Signal (2016) ncbi
mouse monoclonal (3B9)
  • western blot; mouse; 1:100; tbl 1
In order to elucidate a deletion of AMP-activated protein kinase in mouse Sertoli cells that modify germ cell quality, Invitrogen CDH2 antibody (Invitrogen, 3B9) was used in western blot on mouse samples at 1:100 (tbl 1). Mol Cell Endocrinol (2016) ncbi
mouse monoclonal (3B9)
  • western blot; human; fig 5
In order to investigate how CaSm promotes pancreatic cancer, Invitrogen CDH2 antibody (Invitrogen, 33-3900) was used in western blot on human samples (fig 5). Oncogenesis (2016) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - frozen section; rat; 1:100; tbl 2
In order to test if overexpression of Connexin 43 in adjudin-treated rats reseals the disrupted blood-testis barrier and reinitiates spermatogenesis, Invitrogen CDH2 antibody (Invitrogen, 33-3900) was used in immunohistochemistry - frozen section on rat samples at 1:100 (tbl 2). FASEB J (2016) ncbi
mouse monoclonal (3B9)
  • western blot; mouse; fig 7
In order to study postnatal liver maturation and its support by ESRP2 and adult splicing program in hepatocytes, Invitrogen CDH2 antibody (Life Technologies, 33?C3900) was used in western blot on mouse samples (fig 7). Nat Commun (2015) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; human; 1:150; fig 1b
In order to study markers of the epithelial to mesenchymal transition using invasive lobular carcinoma samples, Invitrogen CDH2 antibody (Invitrogen, 3B9) was used in immunohistochemistry - paraffin section on human samples at 1:150 (fig 1b). J Pathol (2016) ncbi
mouse monoclonal (3B9)
  • western blot; rat; 1:1000
  • western blot; African green monkey
In order to determine the functional effects of S368 phosphorylation of connexin 43, Invitrogen CDH2 antibody (Invitrogen, 33?C3900) was used in western blot on rat samples at 1:1000 and in western blot on African green monkey samples . J Cardiovasc Electrophysiol (2016) ncbi
mouse monoclonal (3B9)
  • western blot; human; 1:500; fig 2a
In order to characterize two clones from triple negative breast MDA-MB-231 cancer cells, Invitrogen CDH2 antibody (Invitrogene, 33-3900) was used in western blot on human samples at 1:500 (fig 2a). Exp Cell Res (2015) ncbi
mouse monoclonal (3B9)
  • western blot; human; 1:500; fig 3
In order to identify the role of defective autophagy in cerebral cavernous malformations, Invitrogen CDH2 antibody (Invitrogen, 33-3900) was used in western blot on human samples at 1:500 (fig 3). EMBO Mol Med (2015) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - frozen section; mouse; 1:500
In order to test if Wwp1 regulates connexin 43, Invitrogen CDH2 antibody (Invitrogen, 3B9) was used in immunohistochemistry - frozen section on mouse samples at 1:500. J Mol Cell Cardiol (2015) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; mouse; 1:100; tbl 3
In order to characterize a conditional knock out of ataxia telangiectasia-mutated as a mouse model of pancreatic ductal adenocarcinoma, Invitrogen CDH2 antibody (Zymed, 33-3900) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (tbl 3). Nat Commun (2015) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; domestic horse; 1:500
  • western blot; domestic horse; 1:500
In order to characterize the equine blood-testis barrier during tubular development in normal and cryptorchid stallions, Invitrogen CDH2 antibody (Invitrogen, 33-3900) was used in immunohistochemistry - paraffin section on domestic horse samples at 1:500 and in western blot on domestic horse samples at 1:500. Theriogenology (2015) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry; rat; 1:100
In order to study the role of plastin 3 in ectoplasmic specialization dynamics during spermatogenesis in the rat testis, Invitrogen CDH2 antibody (Invitrogen, 33-3900) was used in immunohistochemistry on rat samples at 1:100. FASEB J (2015) ncbi
mouse monoclonal (3B9)
  • western blot; human; 1:1000
In order to elucidate the contribution of microRNAs in resistance to BRAF inhibitor treatment, Invitrogen CDH2 antibody (Life Technologies, 3B9) was used in western blot on human samples at 1:1000. Pigment Cell Melanoma Res (2015) ncbi
mouse monoclonal (3B9)
  • western blot; human; 1:500
In order to study the tissue factor protein and metastasis initiating cell markers during thrombocytosis, Invitrogen CDH2 antibody (Invitrogen, 33-3900) was used in western blot on human samples at 1:500. BMC Cancer (2015) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; rat; 1:100
  • immunoprecipitation; rat
  • western blot; rat; 1:1000
In order to study the effect of flutamide on the distribution of c-Src and the N-cadherin-beta-catenin complex in the seminiferous epithelium of adult rat, Invitrogen CDH2 antibody (Invitrogen, 33-3900) was used in immunohistochemistry - paraffin section on rat samples at 1:100, in immunoprecipitation on rat samples and in western blot on rat samples at 1:1000. Andrology (2015) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry; rat; 1:200
Invitrogen CDH2 antibody (Invitrogen, 3B9) was used in immunohistochemistry on rat samples at 1:200. Exp Mol Pathol (2015) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry; domestic rabbit; fig 4
  • western blot; domestic rabbit; fig 3
In order to generate and characterize a novel rabbit corneal endothelial cell line, Invitrogen CDH2 antibody (Invitrogen, 3B9) was used in immunohistochemistry on domestic rabbit samples (fig 4) and in western blot on domestic rabbit samples (fig 3). J Tissue Eng Regen Med (2017) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry; mouse
In order to investigate the role of fibroblast growth factor receptor 2 in corneal epithelial cell proliferation and differentiation during embryonic development, Invitrogen CDH2 antibody (Zymed, 33-3900) was used in immunohistochemistry on mouse samples . PLoS ONE (2015) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; human; 1:300
Invitrogen CDH2 antibody (Invitrogen, 3B9) was used in immunohistochemistry - paraffin section on human samples at 1:300. Hum Pathol (2015) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; human; 1:100
Invitrogen CDH2 antibody (Invitrogen, 3B9) was used in immunohistochemistry - paraffin section on human samples at 1:100. J Pathol (2015) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; rat; 1:100
  • western blot; rat; 1:125
In order to investigate the role of rpS6 in blood-testis barrier function, Invitrogen CDH2 antibody (Invitrogen, 33-3900) was used in immunohistochemistry - paraffin section on rat samples at 1:100 and in western blot on rat samples at 1:125. J Cell Sci (2014) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - frozen section; mouse; 1:200; fig s9a
In order to study the initiation and regulation of radial migration, Invitrogen CDH2 antibody (Invitrogen, 333900) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (fig s9a). Nat Commun (2014) ncbi
rat monoclonal (NCD-2)
  • immunohistochemistry; chicken; 1:200; fig 2
  • western blot; chicken; 1:2000; fig 5
In order to report that beta-catenin controls the cell fate and polarity of neuroblasts by modulating the expression and localization of aPKC, Invitrogen CDH2 antibody (Invitrogen, NCD-2) was used in immunohistochemistry on chicken samples at 1:200 (fig 2) and in western blot on chicken samples at 1:2000 (fig 5). Nat Commun (2014) ncbi
mouse monoclonal (3B9)
  • western blot; rat; fig 6b
In order to study the role of calpain activation in hearts subjected to myocardial infarction, Invitrogen CDH2 antibody (Invitrogen, 3B9) was used in western blot on rat samples (fig 6b). J Biol Chem (2014) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - frozen section; mouse; 1:100; fig 8a
In order to elucidate the critical role of TRPV2 in maintenance of cardiac function and structure in mice, Invitrogen CDH2 antibody (life technologies, 3B9) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 8a). Nat Commun (2014) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry; human; 1:500; fig 8
In order to study the contribution of 14-3-3gamma to testis organization and spermatogenesis, Invitrogen CDH2 antibody (Life Technologies, 33-3900) was used in immunohistochemistry on human samples at 1:500 (fig 8). J Cell Sci (2014) ncbi
mouse monoclonal (3B9)
  • western blot; human; 1:1000
In order to develop and characterize a novel three-dimensional cell culture model of ovarian endometriosis, Invitrogen CDH2 antibody (Invitrogen, 3B9) was used in western blot on human samples at 1:1000. J Ovarian Res (2014) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; human
In order to evaluate the role of VEGF-mediated angiogenesis in EMT-induced cancer stemness and tumorigenesis, Invitrogen CDH2 antibody (Zymed, 33-3900) was used in immunohistochemistry - paraffin section on human samples . Cancer Res (2014) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry; human; 1:100; fig 9
In order to describe the magnetic levitation method of 3D cell culturing, Invitrogen CDH2 antibody (Invitrogen, 33-3900) was used in immunohistochemistry on human samples at 1:100 (fig 9). Nat Protoc (2013) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; human; 1:100; tbl 1
In order to describe the molecular pathologic characteristics of urothelial carcinomas subtypes, Invitrogen CDH2 antibody (Invitrogen, 33-3900) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 1). Am J Pathol (2013) ncbi
rat monoclonal (NCD-2)
  • western blot; human; fig 1
  • immunocytochemistry; chicken; fig 2
  • western blot; hamsters; fig 1
In order to investigate mechanisms that regulate the localization of nicotinic receptors, Invitrogen CDH2 antibody (Invitrogen, 13-2100) was used in western blot on human samples (fig 1), in immunocytochemistry on chicken samples (fig 2) and in western blot on hamsters samples (fig 1). PLoS ONE (2013) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry; rat; 1:100
In order to report that Rai14 regulates actin filaments organization in Sertoli cells during the epithelial cycle, Invitrogen CDH2 antibody (Invitrogen, 33-3900) was used in immunohistochemistry on rat samples at 1:100. PLoS ONE (2013) ncbi
mouse monoclonal (3B9)
  • western blot; human; fig 4
In order to compare the histological, biological, and molecular features of 2D and 3D epithelial ovarian cancer cultures, Invitrogen CDH2 antibody (Invitrogen, 33-3900) was used in western blot on human samples (fig 4). Lab Invest (2013) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry; human; 1:150; fig 1
In order to examine E-cadherin-negative ductal carcinoma, Invitrogen CDH2 antibody (Zymed, 33-3900) was used in immunohistochemistry on human samples at 1:150 (fig 1). Histopathology (2013) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; mouse
In order to study the development of fatal cardiac hypertrophy and arrrhythmia in mice overexpressing miRNA-17-92 in heart and smooth muscle, Invitrogen CDH2 antibody (Invitrogen, 3B9) was used in immunohistochemistry - paraffin section on mouse samples . FASEB J (2013) ncbi
mouse monoclonal (3B9)
  • western blot; human; fig 3
In order to study the intercalated disc of the heart, Invitrogen CDH2 antibody (Invitrogen, clone 3B9) was used in western blot on human samples (fig 3). Dev Biol (2013) ncbi
mouse monoclonal (3B9)
  • western blot; human; fig 3
In order to investigate the role of miR-205 in human bladder cancers, Invitrogen CDH2 antibody (Invitrogen, 33-3900) was used in western blot on human samples (fig 3). J Biol Chem (2013) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - frozen section; rat; 1:100
In order to examine the role of actin and tubulin in ectoplasmic specialization, Invitrogen CDH2 antibody (Invitrogen, 33-3900) was used in immunohistochemistry - frozen section on rat samples at 1:100. Spermatogenesis (2012) ncbi
mouse monoclonal (3B9)
  • western blot; mouse; fig 4
In order to study plakoglobin using hypomorphic mice, Invitrogen CDH2 antibody (Invitrogen, 3B9) was used in western blot on mouse samples (fig 4). Genesis (2012) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; human; fig 3
In order to assess the incidence and prognostic significance of the epithelial to mesenchymal transition in cancer of unknown primary, Invitrogen CDH2 antibody (Invitrogen, 3B9) was used in immunohistochemistry - paraffin section on human samples (fig 3). Anticancer Res (2012) ncbi
mouse monoclonal (3B9)
  • western blot; mouse; fig 1
In order to test if beta-catenin is required to maintain cardiac conduction in the absence of plakoglobin, Invitrogen CDH2 antibody (Invitrogen, 3B9) was used in western blot on mouse samples (fig 1). Mol Cell Biol (2012) ncbi
mouse monoclonal (3B9)
  • immunocytochemistry; mouse; fig 5
In order to test if CDH11 is increased in pulmonary fibrosis and contributes its development, Invitrogen CDH2 antibody (Invitrogen, 3B9) was used in immunocytochemistry on mouse samples (fig 5). FASEB J (2012) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; mouse; 1:200
  • western blot; mouse
In order to study the role of the Rac1 GTPase the shaping of the ocular lens, Invitrogen CDH2 antibody (Invitrogen, 3b9) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 and in western blot on mouse samples . Dev Biol (2011) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry; human; 1:20
In order to test is c-met normalizes altered limbal stem cell marker patterns in diabetic corneas, Invitrogen CDH2 antibody (Invitrogen, 3B9) was used in immunohistochemistry on human samples at 1:20. Mol Vis (2011) ncbi
mouse monoclonal (3B9)
  • immunocytochemistry; human; 1:100; fig 4
In order to describe a method to cultivate corneal endothelial cells for transplantation, Invitrogen CDH2 antibody (Invitrogen, 3B9) was used in immunocytochemistry on human samples at 1:100 (fig 4). Tissue Eng Part A (2011) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; human; 1:40; fig 5
In order to use adipose tissue-derived stem cells to generate dental buds, Invitrogen CDH2 antibody (Zymed, 33-3900) was used in immunohistochemistry - paraffin section on human samples at 1:40 (fig 5). Am J Pathol (2011) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry; mouse; fig 6
In order to investigate how plakoglobin affects beta-catenin activity in the heart, Invitrogen CDH2 antibody (Invitrogen, 3B9) was used in immunohistochemistry on mouse samples (fig 6). Mol Cell Biol (2011) ncbi
mouse monoclonal (3B9)
  • western blot; human
In order to determine the role of mammary epithelial cell NF-kapaB signaling in tumor progression in vivo, Invitrogen CDH2 antibody (Zymed, 3B9) was used in western blot on human samples . Cancer Res (2010) ncbi
mouse monoclonal (3B9)
  • immunoprecipitation; rat; fig 2
In order to study the contribution of ZO-1 to cell-cell junction localization, Invitrogen CDH2 antibody (Zymed, 33-3900) was used in immunoprecipitation on rat samples (fig 2). Am J Physiol Heart Circ Physiol (2011) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry; mouse; fig 5
In order to study M-band alterations in heart disease, Invitrogen CDH2 antibody (Invitrogen, 33-3900) was used in immunohistochemistry on mouse samples (fig 5). Basic Res Cardiol (2011) ncbi
mouse monoclonal (3B9)
  • immunocytochemistry; rat; 1:50; tbl 1
In order to test if the function of the blood-testis barrier in affected by adjudin, Invitrogen CDH2 antibody (Zymed, 33-3900) was used in immunocytochemistry on rat samples at 1:50 (tbl 1). Int J Biochem Cell Biol (2010) ncbi
mouse monoclonal (3B9)
  • immunocytochemistry; rat; 1:50; tbl 1
  • western blot; rat; 1:250; tbl 1
In order to study protein trafficking in Sertoli cells, Invitrogen CDH2 antibody (Invitrogen, 33-3900) was used in immunocytochemistry on rat samples at 1:50 (tbl 1) and in western blot on rat samples at 1:250 (tbl 1). Exp Cell Res (2010) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry; human; 1:100; tbl 1
In order to characterize the expression of a number of proteins in tissues from pseudomyxoma peritonei patients, Invitrogen CDH2 antibody (Zymed, 3B9) was used in immunohistochemistry on human samples at 1:100 (tbl 1). Hum Pathol (2010) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; human; 1:200; tbl 2
In order to measure the expression of tenascin-C, osteopontin, and fibronectin in inflammatory myofibroblastic tumor of the lung, Invitrogen CDH2 antibody (Zymed, 3B9) was used in immunohistochemistry - paraffin section on human samples at 1:200 (tbl 2). APMIS (2010) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry; human; fig 3b
In order to examine granzyme B and perforin expression in bladder cancer cell lines and in urothelial carcinoma tissues, Invitrogen CDH2 antibody (Zymed, 3B9) was used in immunohistochemistry on human samples (fig 3b). Int J Cancer (2010) ncbi
mouse monoclonal (3B9)
  • western blot; human; 1:500; fig 6
In order to examine the effects of Slit2 expression on the migration and invasion of invasive glioma cells, Invitrogen CDH2 antibody (Invitrogen, 33-3900) was used in western blot on human samples at 1:500 (fig 6). Neuro Oncol (2009) ncbi
mouse monoclonal (3B9)
  • western blot; human; fig 4
In order to measure expression of E-cadherin and related proteins in breast cancer cell lines, Invitrogen CDH2 antibody (Zymed, 3-B9) was used in western blot on human samples (fig 4). J Cell Physiol (2010) ncbi
rat monoclonal (NCD-2)
  • blocking or activating experiments; Japanese quail
In order to assess the role of N-cadherin in retinoic acid-regulated early cardiovascular morphogenesis, Invitrogen CDH2 antibody (Zymed Laboratories, 13-2100) was used in blocking or activating experiments on Japanese quail samples . Dev Growth Differ (2009) ncbi
mouse monoclonal (3B9)
  • western blot; human; fig 1
In order to determine the localization and function of N-cadherin in human spermatozoa and oocytes, Invitrogen CDH2 antibody (Zymed, 33-3900) was used in western blot on human samples (fig 1). Int J Androl (2010) ncbi
mouse monoclonal (3B9)
  • western blot; mouse; fig 7
In order to observe the spatial expression of the mu-opioid receptor, Invitrogen CDH2 antibody (Zymed, 33-3900) was used in western blot on mouse samples (fig 7). J Cell Mol Med (2009) ncbi
rat monoclonal (NCD-2)
  • immunohistochemistry; chicken; fig 5
In order to examine the signaling capabilities of N-cadherin that control voltage activated calcium influx, Invitrogen CDH2 antibody (Zymed, 13-2100) was used in immunohistochemistry on chicken samples (fig 5). Mol Cell Neurosci (2009) ncbi
mouse monoclonal (3B9)
  • western blot; human; fig 3
In order to examine the effects of connexin-43 expression in breast cancer cells, Invitrogen CDH2 antibody (Zymed, 33-3900) was used in western blot on human samples (fig 3). Clin Exp Metastasis (2008) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; human; 1:50; fig 3b
  • western blot; human; 1:250; fig 5b
In order to assess if E- and N-cadherin expression has diagnostic value for intrahepatic cholangiocarcinoma, Invitrogen CDH2 antibody (Zymed, 3B9) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 3b) and in western blot on human samples at 1:250 (fig 5b). Mod Pathol (2009) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; human; 1:200
In order to measure Twist and E- and N-cadherin expression in human primary bladder tumor from tobacco and non-tobacco users and evaluate their prognostic value, Invitrogen CDH2 antibody (Zymed Laboratories, 3B9) was used in immunohistochemistry - paraffin section on human samples at 1:200. Urol Oncol (2009) ncbi
mouse monoclonal (3B9)
  • western blot; human; fig 3c
  • immunocytochemistry; mouse; fig 6
In order to examine cadherin expression in mouse fibroblast-like synoviocytes, Invitrogen CDH2 antibody (Zymed, 3B9) was used in western blot on human samples (fig 3c) and in immunocytochemistry on mouse samples (fig 6). Arthritis Rheum (2008) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry; mouse; fig 3
In order to explore the relationship between N-cadherin and connexin43 in the heart, Invitrogen CDH2 antibody (Zymed, 3B9) was used in immunohistochemistry on mouse samples (fig 3). J Mol Cell Cardiol (2008) ncbi
mouse monoclonal (3B9)
  • immunocytochemistry; rat; fig 2
In order to examine the distribution of nectin-1 and afadin during hippocampal synapse formation, Invitrogen CDH2 antibody (Zymed, 3B9) was used in immunocytochemistry on rat samples (fig 2). J Comp Neurol (2008) ncbi
mouse monoclonal (3B9)
  • western blot; human; fig 6
In order to find that basic fibroblast growth factor downregulates typical cadherin expression on the surface of human umbilical vein endothelial cells via FGF receptor 1 signaling, Invitrogen CDH2 antibody (Zymed, 3B9) was used in western blot on human samples (fig 6). Exp Cell Res (2008) ncbi
mouse monoclonal (3B9)
  • western blot; human; fig 10
In order to propose that a paucity of pericytes in the germinal matrix vasculature contributes to its propensity to hemorrhage, Invitrogen CDH2 antibody (Zymed Laboratories, 33-3900) was used in western blot on human samples (fig 10). J Neurosci (2007) ncbi
mouse monoclonal (3B9)
  • western blot; rat; 0.1 ug/ml
In order to test if aconitine affects connexin43 phosphorylation and intracellular calcium oscillation patterns in cultured ventricular myocytes of neonatal rats, Invitrogen CDH2 antibody (Zymed, 33-3900) was used in western blot on rat samples at 0.1 ug/ml. Toxicol In Vitro (2007) ncbi
mouse monoclonal (3B9)
  • western blot; mouse
In order to study epigenetic silencing and activation of the MOR gene, Invitrogen CDH2 antibody (Zymed, 33-3900) was used in western blot on mouse samples . Mol Cell Biol (2007) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - frozen section; rat; 1:50
In order to determine the distribution pattern and physiological function of coxsackie and adenovirus receptor in the testis, Invitrogen CDH2 antibody (Zymed Laboratories, 33-3900) was used in immunohistochemistry - frozen section on rat samples at 1:50. Exp Cell Res (2007) ncbi
mouse monoclonal (3B9)
  • immunocytochemistry; mouse; 1:100; fig 2
In order to identify the membrane ruffle-targeting region of beta-catenin, Invitrogen CDH2 antibody (Zymed, 33-3900) was used in immunocytochemistry on mouse samples at 1:100 (fig 2). J Biol Chem (2007) ncbi
mouse monoclonal (3B9)
  • western blot; mouse; 1:1000
In order to examine the effects of mammary gland-specific deletion of Bin1 on initiation and progression of breast cancer in mice, Invitrogen CDH2 antibody (Zymed, 3B9) was used in western blot on mouse samples at 1:1000. Cancer Res (2007) ncbi
rat monoclonal (NCD-2)
  • immunohistochemistry - paraffin section; chicken; 5 ug/ml; fig 1
In order to review molecules that are expressed by supporting cells in the avian ear, Invitrogen CDH2 antibody (Zymed, NCD-2) was used in immunohistochemistry - paraffin section on chicken samples at 5 ug/ml (fig 1). Hear Res (2007) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry; mouse
In order to compare the eye defects of dyl and Foxe3 mutant mice, Invitrogen CDH2 antibody (Zymed, 33-3900) was used in immunohistochemistry on mouse samples . Dev Biol (2007) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry; dogs; 1:25; fig 5
In order to investigate genes regulated by Snail, Slug, and E47 transcription factors, Invitrogen CDH2 antibody (Zymed, 3B9) was used in immunohistochemistry on dogs samples at 1:25 (fig 5). Cancer Res (2006) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; human; 1:200
In order to discover if N-cadherin expression is associated with the bladder tumor progression, Invitrogen CDH2 antibody (Zymed, 3B9) was used in immunohistochemistry - paraffin section on human samples at 1:200. Clin Cancer Res (2006) ncbi
mouse monoclonal (3B9)
  • western blot; human; fig 6
In order to report that Notch1 signaling drives the vertical growth phase of primary melanoma, Invitrogen CDH2 antibody (Zymed, 33-3900) was used in western blot on human samples (fig 6). Cancer Res (2006) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; rat; tbl 1
  • immunoprecipitation; rat; tbl 1
  • western blot; rat; tbl 1
In order to determine the role of soluble guanylate cyclase in junction restructuring of the seminiferous epithelium of rat testis, Invitrogen CDH2 antibody (Invitrogen, 33-3900) was used in immunohistochemistry - paraffin section on rat samples (tbl 1), in immunoprecipitation on rat samples (tbl 1) and in western blot on rat samples (tbl 1). J Cell Physiol (2006) ncbi
mouse monoclonal (3B9)
  • immunocytochemistry; mouse; fig 4
  • western blot; mouse; fig 1
In order to identify and characterize a novel classical cadherin adhesion system, Invitrogen CDH2 antibody (Zymed, 3B9) was used in immunocytochemistry on mouse samples (fig 4) and in western blot on mouse samples (fig 1). J Cell Sci (2005) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry; human; fig 5
  • western blot; human; fig 4
In order to study the intrinsic molecular programs that determine tumor differentiation, Invitrogen CDH2 antibody (Zymed Laboratories, 33-3900) was used in immunohistochemistry on human samples (fig 5) and in western blot on human samples (fig 4). J Pathol (2005) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; human
In order to compare clinicopathological characteristics and immunohistochemical profiles of simultaneous bilateral breast cancer and corresponding lymph node metastases, Invitrogen CDH2 antibody (Zymed, 3B9) was used in immunohistochemistry - paraffin section on human samples . Histol Histopathol (2005) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - frozen section; rat; 1:100; tbl 1
In order to test if TGF-beta3 regulates anchoring junction dynamics in the blood-testis barrier, Invitrogen CDH2 antibody (Zymed, 33-3900) was used in immunohistochemistry - frozen section on rat samples at 1:100 (tbl 1). Dev Biol (2005) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - frozen section; rat; 1:100; tbl 1
In order to study regulation of the blood-testis barrier, Invitrogen CDH2 antibody (Zymed, 33-3900) was used in immunohistochemistry - frozen section on rat samples at 1:100 (tbl 1). J Cell Physiol (2005) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; mouse
In order to investigate the effect of N-cadherin misexpression in mice, Invitrogen CDH2 antibody (Zymed, 3B9) was used in immunohistochemistry - paraffin section on mouse samples . J Cell Biochem (2005) ncbi
rat monoclonal (NCD-2)
  • immunocytochemistry; mouse
In order to review the differential adhesion hypothesis, Invitrogen CDH2 antibody (Zymed, NCD-2) was used in immunocytochemistry on mouse samples . Dev Biol (2005) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; human; 1:200; tbl 1
In order to measure the E- and N-cadherin and beta- and alpha-catenin expression in benign and malignant epithelial neoplasms of the ovary and correlate expression with tumor staging, histological grade, and presence of metastases during evolution, Invitrogen CDH2 antibody (ZYMED, 3B9) was used in immunohistochemistry - paraffin section on human samples at 1:200 (tbl 1). Gynecol Oncol (2004) ncbi
mouse monoclonal (3B9)
  • western blot; human; fig 4
In order to test if carcinoma cells form gap junctions with bone cells and assess the function of this interaction, Invitrogen CDH2 antibody (Zymed, 33-3900) was used in western blot on human samples (fig 4). Int J Cancer (2004) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry; human; 1:125; tbl 2
In order to report on a case of pilomatrix carcinoma with lymph node metastases, Invitrogen CDH2 antibody (ZYMED, 3B9) was used in immunohistochemistry on human samples at 1:125 (tbl 2). J Cutan Pathol (2004) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; rat; 1:100; fig 6
In order to investigate zyxin, axin, and Wiskott-Aldrich syndrome protein in the seminiferous epithelium, Invitrogen CDH2 antibody (Zymed, 33-3900) was used in immunohistochemistry - paraffin section on rat samples at 1:100 (fig 6). J Androl (2004) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; human; tbl 1
In order to present three cases of primary peritoneal malignant mixed mullerian tumors, Invitrogen CDH2 antibody (Zymed, 3B9) was used in immunohistochemistry - paraffin section on human samples (tbl 1). Int J Gynecol Cancer (2003) ncbi
mouse monoclonal (3B9)
  • western blot; rat
In order to investigate the beta1-integrin/laminin gamma3 complex, MMP-2, MT1-MMP and TIMP-2 at the apical ectoplasmic specialization, Invitrogen CDH2 antibody (Zymed, 33-3900) was used in western blot on rat samples . Biol Reprod (2004) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry; human; 1:20; fig 3
In order to study expression of E- and N-cadherin in mesotheliomas and adenocarcinomas, Invitrogen CDH2 antibody (Zymed, 3B9) was used in immunohistochemistry on human samples at 1:20 (fig 3). Hum Pathol (2003) ncbi
rat monoclonal (NCD-2)
  • flow cytometry; chicken
In order to examine cadherin-subtype-specific binding specificities, Invitrogen CDH2 antibody (Zymed, NCD-2) was used in flow cytometry on chicken samples . Dev Biol (2003) ncbi
mouse monoclonal (3B9)
  • immunocytochemistry; mouse; 1:100
In order to test if N-cadherin is required for normal myocyte structure and function, Invitrogen CDH2 antibody (Zymed, 3B9) was used in immunocytochemistry on mouse samples at 1:100. J Cell Sci (2003) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - frozen section; rat
In order to show that the cadherin/catenin complex is present between Sertoli and germ cells and is used for the assembly of functional adheren junctions, Invitrogen CDH2 antibody (Zymed, 33-3900,) was used in immunohistochemistry - frozen section on rat samples . Biol Reprod (2003) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; human; 1:400; fig 1
In order to investigate the relationship between primary mucoepidermoid carcinoma of the thyroid and papillary thyroid carcinoma, Invitrogen CDH2 antibody (Zymed, 3B9) was used in immunohistochemistry - paraffin section on human samples at 1:400 (fig 1). Virchows Arch (2002) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; mouse; 1:100; fig 2
  • western blot; mouse; 1:1000; fig 1
In order to explore the effect of cadherin specificity on cardiac structure and function, Invitrogen CDH2 antibody (Zymed, 3B9) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 2) and in western blot on mouse samples at 1:1000 (fig 1). J Cell Sci (2002) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; human; 1:400; tbl 2
In order to investigate the expression of E-, N-, and P-cadherin in ductal carcinoma in situ of the breast, Invitrogen CDH2 antibody (Zymed, 3B9) was used in immunohistochemistry - paraffin section on human samples at 1:400 (tbl 2). Virchows Arch (2002) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; human; 1:200
In order to examine epithelial-type cadherin and neural-type cadherin as diagnostic markers of malignant noncarcinomatous neoplasms, Invitrogen CDH2 antibody (Zymed, 3B9) was used in immunohistochemistry - paraffin section on human samples at 1:200. Arch Pathol Lab Med (2002) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; human; tbl 1
In order to discuss using expression of cadherins and catenins as prognosis markers for cancer, Invitrogen CDH2 antibody (Zymed, clone 3B9) was used in immunohistochemistry - paraffin section on human samples (tbl 1). J Mammary Gland Biol Neoplasia (2001) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry; human; 1:400; fig 1
In order to describe the clinicopathological features of papillary thyroid carcinoma, Invitrogen CDH2 antibody (Zymed, clone 3B9) was used in immunohistochemistry on human samples at 1:400 (fig 1). J Pathol (2001) ncbi
mouse monoclonal (3B9)
  • western blot; human
In order to examine adhesion- versus a beta-catenin signaling-dependent mechanisms of E-cadherin tumor suppressor activity, Invitrogen CDH2 antibody (Zymed, 3B9) was used in western blot on human samples . J Cell Biol (2001) ncbi
mouse monoclonal (3B9)
  • immunoprecipitation; human
  • western blot; human
In order to assess the functional significance of N-cadherin in melanoma cells, Invitrogen CDH2 antibody (Zymed, 33-3900) was used in immunoprecipitation on human samples and in western blot on human samples . Cancer Res (2001) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; mouse; 1:100
In order to investigate the role of N-cadherin in cardiogenesis, Invitrogen CDH2 antibody (Zymed, 3B9) was used in immunohistochemistry - paraffin section on mouse samples at 1:100. Development (2001) ncbi
rat monoclonal (NCD-2)
  • immunohistochemistry; mouse
In order to determine the role of Foxf1 in mouse development, Invitrogen CDH2 antibody (Zymed, NCD-2) was used in immunohistochemistry on mouse samples . Development (2001) ncbi
mouse monoclonal (3B9)
  • immunohistochemistry - paraffin section; mouse; 1:500
In order to study lens development in Pax6(Sey)(-1Neu)/+ mouse embryos, Invitrogen CDH2 antibody (Zymed, 33-3900) was used in immunohistochemistry - paraffin section on mouse samples at 1:500. Development (2000) ncbi
Abcam
domestic rabbit polyclonal
  • immunohistochemistry; human; loading ...; fig 2k
  • western blot; human; loading ...; fig 2g, 3g
Abcam CDH2 antibody (Abcam, ab76057) was used in immunohistochemistry on human samples (fig 2k) and in western blot on human samples (fig 2g, 3g). Cell Death Dis (2021) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig s6b
Abcam CDH2 antibody (Abcam, ab76057) was used in western blot on mouse samples at 1:1000 (fig s6b). Nat Commun (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 1e, 3b, 4d
Abcam CDH2 antibody (Abcam, ab76057) was used in western blot on human samples at 1:1000 (fig 1e, 3b, 4d). Sci Rep (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 1f,
Abcam CDH2 antibody (Abcam, Cambridge, England, ab76057) was used in western blot on human samples at 1:1000 (fig 1f, ). Integr Cancer Ther (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry knockout validation; mouse; 1:1000; loading ...; fig s3b
Abcam CDH2 antibody (Abcam, ab76057) was used in immunohistochemistry knockout validation on mouse samples at 1:1000 (fig s3b). Cells (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3c
Abcam CDH2 antibody (Abcam, ab76057) was used in western blot on human samples (fig 3c). J Exp Clin Cancer Res (2018) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; loading ...; fig 4b
  • western blot; human; loading ...; fig 4a
Abcam CDH2 antibody (Abcam, ab76057) was used in immunocytochemistry on human samples (fig 4b) and in western blot on human samples (fig 4a). PLoS ONE (2017) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; fig 6d
Abcam CDH2 antibody (Abcam, ab76057) was used in western blot on mouse samples at 1:1000 (fig 6d). J Cell Biol (2017) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; rat; loading ...; fig 1a
In order to visualize the interaction of claudin, ZO-1 and actin in epithelial tight juntions., Abcam CDH2 antibody (Abcam, Ab76057) was used in immunocytochemistry on rat samples (fig 1a). Mol Biol Cell (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; human; loading ...; fig 1e
  • western blot; human; loading ...; fig 2h
  • western blot; mouse; loading ...; fig 4b
Abcam CDH2 antibody (Abcam, ab76057) was used in immunohistochemistry on human samples (fig 1e), in western blot on human samples (fig 2h) and in western blot on mouse samples (fig 4b). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; mouse; 1:50; fig 3
In order to describe a new technique based on resin-embedded multicycle imaging to study proteins in-situ, Abcam CDH2 antibody (Abcam, ab76057) was used in immunocytochemistry on mouse samples at 1:50 (fig 3). Sci Rep (2016) ncbi
BD Biosciences
mouse monoclonal (32/N-Cadherin)
  • western blot; human; 1:2000; loading ...; fig 4f
BD Biosciences CDH2 antibody (BD Biosciences, 610920) was used in western blot on human samples at 1:2000 (fig 4f). iScience (2022) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; human; loading ...
BD Biosciences CDH2 antibody (BD Bioscience, 610920) was used in western blot on human samples . Nat Commun (2022) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; mouse; loading ...; fig 1f, 4d
BD Biosciences CDH2 antibody (BD Biosciences, 610920) was used in western blot on mouse samples (fig 1f, 4d). Sci Adv (2022) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunohistochemistry; mouse; 1:100; fig 4k
BD Biosciences CDH2 antibody (BD, 610920) was used in immunohistochemistry on mouse samples at 1:100 (fig 4k). Commun Biol (2022) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; human; 1:100; fig 3e
BD Biosciences CDH2 antibody (BD Bioscience, 610920) was used in western blot on human samples at 1:100 (fig 3e). Am J Cancer Res (2022) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunohistochemistry - frozen section; human; 1:500; fig 2j
BD Biosciences CDH2 antibody (BD Biosciences, 610920) was used in immunohistochemistry - frozen section on human samples at 1:500 (fig 2j). Nat Commun (2021) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; human; loading ...; fig 1e
BD Biosciences CDH2 antibody (BD Bioscience, 640920) was used in western blot on human samples (fig 1e). Cancers (Basel) (2021) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunohistochemistry - frozen section; mouse; 1:1000; loading ...; fig s1e
  • immunocytochemistry; mouse; loading ...; fig 1c
BD Biosciences CDH2 antibody (BD, 610920) was used in immunohistochemistry - frozen section on mouse samples at 1:1000 (fig s1e) and in immunocytochemistry on mouse samples (fig 1c). Front Cell Dev Biol (2021) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; human; fig 1d
BD Biosciences CDH2 antibody (BD Biosciences, 610921) was used in western blot on human samples (fig 1d). Cancers (Basel) (2021) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; human; 1:1000; loading ...; fig 2f
BD Biosciences CDH2 antibody (BD Transduction Laboratories, 610920) was used in western blot on human samples at 1:1000 (fig 2f). Commun Biol (2021) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunohistochemistry; mouse; 1:250; loading ...; fig s3-1e
BD Biosciences CDH2 antibody (BD Biosciences, 610921) was used in immunohistochemistry on mouse samples at 1:250 (fig s3-1e). elife (2021) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; human; 1:500; loading ...; fig 5a
BD Biosciences CDH2 antibody (BD Biosciences, 610921) was used in western blot on human samples at 1:500 (fig 5a). Nat Commun (2021) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; human; 1:5000; loading ...; fig 5f
BD Biosciences CDH2 antibody (BD, 610921) was used in western blot on human samples at 1:5000 (fig 5f). elife (2021) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunocytochemistry; mouse; 1:200; loading ...; fig 4a
BD Biosciences CDH2 antibody (Transduction Laboratories, 610920) was used in immunocytochemistry on mouse samples at 1:200 (fig 4a). J Neurochem (2021) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunohistochemistry; human; loading ...; fig 3b
BD Biosciences CDH2 antibody (BD Biosciences, 610920) was used in immunohistochemistry on human samples (fig 3b). elife (2020) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; human; 1:2500; loading ...; fig 5
BD Biosciences CDH2 antibody (BD Biosciences, 610920) was used in western blot on human samples at 1:2500 (fig 5). Oncol Lett (2020) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 3a
BD Biosciences CDH2 antibody (BD bioscience, 610920) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 3a). elife (2020) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; human; 1:500; loading ...; fig 1g
BD Biosciences CDH2 antibody (BD Biosciences, 610920) was used in western blot on human samples at 1:500 (fig 1g). Proc Natl Acad Sci U S A (2020) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunohistochemistry; mouse; loading ...; fig 2c
BD Biosciences CDH2 antibody (BD Biosciences, 610920) was used in immunohistochemistry on mouse samples (fig 2c). Cell Rep (2020) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; mouse; 1:2000; loading ...; fig 5s1a
BD Biosciences CDH2 antibody (BD Biosciences, 32) was used in western blot on mouse samples at 1:2000 (fig 5s1a). elife (2020) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunocytochemistry; human; 1:250; loading ...; fig 4e
BD Biosciences CDH2 antibody (BD Biosciences, clone 32) was used in immunocytochemistry on human samples at 1:250 (fig 4e). PLoS Biol (2019) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunohistochemistry; mouse; 1:100; fig 7h
BD Biosciences CDH2 antibody (BD Biosciences, 610920) was used in immunohistochemistry on mouse samples at 1:100 (fig 7h). Nat Commun (2019) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunohistochemistry; mouse; 1:150; loading ...; fig 4e
BD Biosciences CDH2 antibody (BD Biosciences, 610921) was used in immunohistochemistry on mouse samples at 1:150 (fig 4e). elife (2019) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunocytochemistry; human; loading ...; fig 1e
BD Biosciences CDH2 antibody (BD Bioscience, 610920) was used in immunocytochemistry on human samples (fig 1e). Cell Death Dis (2019) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunoprecipitation; human; 1:1000; loading ...; fig 7a
BD Biosciences CDH2 antibody (BD, 610921) was used in immunoprecipitation on human samples at 1:1000 (fig 7a). Nat Commun (2019) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunohistochemistry - paraffin section; mouse; 1:300; loading ...; fig 6a
  • western blot; mouse; 1:200; loading ...; fig 6c
BD Biosciences CDH2 antibody (BD, 610920) was used in immunohistochemistry - paraffin section on mouse samples at 1:300 (fig 6a) and in western blot on mouse samples at 1:200 (fig 6c). Biosci Rep (2019) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; human; loading ...; fig 4d
BD Biosciences CDH2 antibody (BD Transduction Laboratories, 610920) was used in western blot on human samples (fig 4d). Sci Rep (2018) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunohistochemistry - paraffin section; human; 1:150; loading ...; fig 7s2g
BD Biosciences CDH2 antibody (BD Transduction Laboratories, 610920) was used in immunohistochemistry - paraffin section on human samples at 1:150 (fig 7s2g). elife (2018) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; human; 1:5000; loading ...; fig 1a
BD Biosciences CDH2 antibody (BD Biosciences, 610921) was used in western blot on human samples at 1:5000 (fig 1a). Nat Commun (2018) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; human; loading ...; fig 2b
BD Biosciences CDH2 antibody (BD Biosciences, 610920) was used in western blot on human samples (fig 2b). Cell Death Dis (2018) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; human; loading ...; fig 4e
BD Biosciences CDH2 antibody (BD BioScience, 610921) was used in western blot on human samples (fig 4e). EMBO J (2018) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunohistochemistry; mouse; loading ...; fig 8a
BD Biosciences CDH2 antibody (BD Biosciences, 610,920) was used in immunohistochemistry on mouse samples (fig 8a). Acta Neuropathol Commun (2017) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; human; 1:2500; loading ...; fig 4a
BD Biosciences CDH2 antibody (BD Biosciences, 610920) was used in western blot on human samples at 1:2500 (fig 4a). Oncotarget (2017) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunohistochemistry - frozen section; rat; loading ...; fig 6c
  • western blot; rat; loading ...; fig 6i
BD Biosciences CDH2 antibody (Becton-Dickinson, 610920) was used in immunohistochemistry - frozen section on rat samples (fig 6c) and in western blot on rat samples (fig 6i). Development (2017) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunohistochemistry knockout validation; mouse; loading ...; fig 2a, 2b
  • western blot knockout validation; mouse; loading ...; fig 2c
BD Biosciences CDH2 antibody (BD, 610921) was used in immunohistochemistry knockout validation on mouse samples (fig 2a, 2b) and in western blot knockout validation on mouse samples (fig 2c). Dev Biol (2017) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; mouse; loading ...; fig 7b
BD Biosciences CDH2 antibody (BD, 610920) was used in western blot on mouse samples (fig 7b). Cancer Res (2017) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunohistochemistry; mouse; 1:1000; loading ...; tbl 1
BD Biosciences CDH2 antibody (BD Biosciences, 610920) was used in immunohistochemistry on mouse samples at 1:1000 (tbl 1). J Comp Neurol (2017) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunocytochemistry; human; loading ...; fig 4c
  • western blot; human; loading ...; fig 4a
In order to investigate Rac1 activity and inhibition in gastric adenocarcinoma cells and mouse xenograft models for epithelial-to-mesenchymal transition and cancer stem-like cell phenotypes, BD Biosciences CDH2 antibody (BD Biosciences, 610920) was used in immunocytochemistry on human samples (fig 4c) and in western blot on human samples (fig 4a). Mol Cancer Res (2017) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; human; 1:1000; fig 5b
In order to elucidate the mechanism by which 15d-PGJ2 suppresses human thyroid carcinoma cell migration, BD Biosciences CDH2 antibody (BD Biosciences, 610920) was used in western blot on human samples at 1:1000 (fig 5b). Oncol Lett (2017) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; human; loading ...; fig 4c
In order to investigate the role of CRB3 downregulation in maintaining breast cancer stem cells, BD Biosciences CDH2 antibody (BD Biosciences, 610920) was used in western blot on human samples (fig 4c). Oncogenesis (2017) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunocytochemistry; human; fig 2b
BD Biosciences CDH2 antibody (BD Bioscience, 610920) was used in immunocytochemistry on human samples (fig 2b). Cell Stem Cell (2017) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunocytochemistry; human; 1:2000; fig 4b
  • western blot; human; 1:2000; loading ...; fig 1b
BD Biosciences CDH2 antibody (BD Biosciences, 610920) was used in immunocytochemistry on human samples at 1:2000 (fig 4b) and in western blot on human samples at 1:2000 (fig 1b). Nat Commun (2016) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunohistochemistry - frozen section; mouse; 1:500; loading ...; fig 8a
BD Biosciences CDH2 antibody (BD Transduction Labs, 610920) was used in immunohistochemistry - frozen section on mouse samples at 1:500 (fig 8a). Neural Dev (2016) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; mouse; 1:1000; loading ...; fig 5a
In order to propose a role for KIDLIA in neurodevelopment and autism, BD Biosciences CDH2 antibody (BD Biosciences, 610920) was used in western blot on mouse samples at 1:1000 (fig 5a). Eneuro (2016) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunocytochemistry; human; loading ...; fig s6i
  • immunoprecipitation; mouse; loading ...; fig 5b
In order to demonstrate that actin-binding protein filamin A interacts with actin-nucleating protein formin 2, BD Biosciences CDH2 antibody (BD Biosciences, 610920) was used in immunocytochemistry on human samples (fig s6i) and in immunoprecipitation on mouse samples (fig 5b). Development (2016) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunocytochemistry; human; fig 1b
  • western blot; human; fig 1a
In order to determine the effects of high glucose on the epithelial-mesenchymal transition in retinal pigment epithelial cells, BD Biosciences CDH2 antibody (BD Biosciences, 610920) was used in immunocytochemistry on human samples (fig 1b) and in western blot on human samples (fig 1a). Int J Mol Med (2016) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; rat; 1:2000; fig 3b
BD Biosciences CDH2 antibody (BD Bioscience, 610920) was used in western blot on rat samples at 1:2000 (fig 3b). PLoS ONE (2016) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; mouse; fig s2a
  • western blot; human; loading ...; fig s2a
BD Biosciences CDH2 antibody (BD-Transduction Laboratories, 610920) was used in western blot on mouse samples (fig s2a) and in western blot on human samples (fig s2a). J Clin Invest (2016) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; human; loading ...; fig 4e
BD Biosciences CDH2 antibody (BD Biosciences, 610920) was used in western blot on human samples (fig 4e). Oncogenesis (2016) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunohistochemistry - paraffin section; mouse; 1:100; fig 3
In order to describe a role for ADAMTS9 in ocular morphogenesis, BD Biosciences CDH2 antibody (BD Transduction Laboratories, 610920) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 3). Sci Rep (2016) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunocytochemistry; human; 1:25; fig 1
  • immunohistochemistry; human; 1:25; fig 7
  • western blot; human; 1:1000; fig 1
In order to investigate the contribution of DNA methyltransferase 1 to the epithelial-mesenchymal transition and cancer stem cells, BD Biosciences CDH2 antibody (BD Biosciences, 610921) was used in immunocytochemistry on human samples at 1:25 (fig 1), in immunohistochemistry on human samples at 1:25 (fig 7) and in western blot on human samples at 1:1000 (fig 1). Neoplasia (2016) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunocytochemistry; dogs; fig 6d
  • western blot; dogs; fig 6a
  • western blot; human; fig 6a
In order to report that TrkC contributes to tumorigenicity, metastasis, and self-renewal traits of metastatic breast cancer, BD Biosciences CDH2 antibody (BD Transduction, 610920) was used in immunocytochemistry on dogs samples (fig 6d), in western blot on dogs samples (fig 6a) and in western blot on human samples (fig 6a). Sci Rep (2016) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; human; loading ...; fig 3b, 4c
  • western blot; mouse; loading ...; fig 2c
BD Biosciences CDH2 antibody (BD BIOSCIENCES, 610920) was used in western blot on human samples (fig 3b, 4c) and in western blot on mouse samples (fig 2c). Oncotarget (2016) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunocytochemistry; human; loading ...; fig 5d
  • western blot; human; loading ...; fig 5c
  • immunohistochemistry - paraffin section; mouse; 1:100; fig 6c
BD Biosciences CDH2 antibody (BD Transduction Laboratories, 610920) was used in immunocytochemistry on human samples (fig 5d), in western blot on human samples (fig 5c) and in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 6c). Oncotarget (2016) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunohistochemistry; mouse; loading ...; fig st1
In order to develop a method for super-resolution imaging of the multiscale organization of intact tissues and use it to image the mouse brain, BD Biosciences CDH2 antibody (BD, 610920) was used in immunohistochemistry on mouse samples (fig st1). Nat Biotechnol (2016) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunocytochemistry; human; fig 2a
BD Biosciences CDH2 antibody (BD Biosciences, 32) was used in immunocytochemistry on human samples (fig 2a). BMC Cancer (2016) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunocytochemistry; human; 1:100; fig 1
BD Biosciences CDH2 antibody (BD Biosciences, 610920) was used in immunocytochemistry on human samples at 1:100 (fig 1). Nat Commun (2016) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunohistochemistry - paraffin section; mouse; fig 7
In order to use a blinded study to examine the effects of ANGPTL8 upon beta-cell proliferation, BD Biosciences CDH2 antibody (BD Biosciences, 610920) was used in immunohistochemistry - paraffin section on mouse samples (fig 7). PLoS ONE (2016) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunohistochemistry - paraffin section; mouse; fig 4
  • western blot; mouse; fig 6
In order to learn of the restriction in brain cell types and possible connection to autism by alphaT-catenin, BD Biosciences CDH2 antibody (BD Transduction Laboratories, 610920) was used in immunohistochemistry - paraffin section on mouse samples (fig 4) and in western blot on mouse samples (fig 6). J Mol Psychiatry (2016) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; human; fig 4
BD Biosciences CDH2 antibody (BD, 610921) was used in western blot on human samples (fig 4). Nat Commun (2016) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; human; 1:10,000; fig 1
BD Biosciences CDH2 antibody (BD Biosciences, 610920) was used in western blot on human samples at 1:10,000 (fig 1). Schizophr Res (2016) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunocytochemistry; African green monkey; 1:200; fig 1
  • western blot; African green monkey; fig 6
  • western blot; human; fig 7
BD Biosciences CDH2 antibody (BD Transduction Laboratories, 610921) was used in immunocytochemistry on African green monkey samples at 1:200 (fig 1), in western blot on African green monkey samples (fig 6) and in western blot on human samples (fig 7). Traffic (2016) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; human; 1:2000; fig 4
BD Biosciences CDH2 antibody (BD, 610921) was used in western blot on human samples at 1:2000 (fig 4). PLoS ONE (2016) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunohistochemistry; mouse; 1:500; fig 5
  • western blot; mouse; fig 4a
BD Biosciences CDH2 antibody (BD, 610921) was used in immunohistochemistry on mouse samples at 1:500 (fig 5) and in western blot on mouse samples (fig 4a). Invest Ophthalmol Vis Sci (2016) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunocytochemistry; mouse; 1:500; fig 2
BD Biosciences CDH2 antibody (BD Biosciences, 610920) was used in immunocytochemistry on mouse samples at 1:500 (fig 2). Stem Cell Reports (2016) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunohistochemistry - paraffin section; human; 1:200; fig 3
In order to study an in vitro model for tumor progression modeling and drug screening by using a reductionist metastasis-on-a-chip platform, BD Biosciences CDH2 antibody (BD Biosciences, 610921) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 3). Biotechnol Bioeng (2016) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; human; 1:2000; fig 2f
BD Biosciences CDH2 antibody (BD, 32) was used in western blot on human samples at 1:2000 (fig 2f). Nat Commun (2016) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; human; fig 3
BD Biosciences CDH2 antibody (BD Biosciences, 610920) was used in western blot on human samples (fig 3). Oncogene (2016) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; human; fig 3
BD Biosciences CDH2 antibody (BD Transduction Lab., 610920) was used in western blot on human samples (fig 3). Mol Cancer (2015) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; human; 1:2500; loading ...; fig 2a
BD Biosciences CDH2 antibody (BD Biosciences, 610920) was used in western blot on human samples at 1:2500 (fig 2a). Vascul Pharmacol (2016) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; human; fig 2
In order to characterize the interaction of TRPC6 with APP to inhibit its cleavage by gamma-secretase and reduce A-beta production, BD Biosciences CDH2 antibody (BD, 610921) was used in western blot on human samples (fig 2). Nat Commun (2015) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunohistochemistry; human; 1:25; fig s2
In order to analyze propagation of oestrogen-responsive and oestrogen receptor-positive normal human breast cells in culture, BD Biosciences CDH2 antibody (BD Transduction Laboratories, 610920) was used in immunohistochemistry on human samples at 1:25 (fig s2). Nat Commun (2015) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunocytochemistry; mouse; 1:100; fig 1d
In order to characterize the role of p19ARF depletion and cell escape in regards to liver sinusoidal endothelial cells, BD Biosciences CDH2 antibody (BD Transduction Laboratories, 610920) was used in immunocytochemistry on mouse samples at 1:100 (fig 1d). PLoS ONE (2015) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunohistochemistry - frozen section; mouse; 1:200; fig 8
In order to investigate the developmental processes that regulate the formation of unique inner ear cell types, BD Biosciences CDH2 antibody (BD Bioscience, 610920) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (fig 8). Nat Commun (2015) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunohistochemistry; mouse
In order to determine the functions of EHD1, BD Biosciences CDH2 antibody (BD-Transduction laboratories, 610920) was used in immunohistochemistry on mouse samples . Dev Biol (2015) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; rat; 1:500; fig 4b
In order to identify novel molecules in peripheral myelination by spatial mapping of juxtacrine axo-glial interactions, BD Biosciences CDH2 antibody (BD Bioscience, 610920) was used in western blot on rat samples at 1:500 (fig 4b). Nat Commun (2015) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; rat; 1:500; fig 3
In order to study how cellular localization affects DHHC5 activity, BD Biosciences CDH2 antibody (BD Transduction Laboratories, 610921) was used in western blot on rat samples at 1:500 (fig 3). Nat Commun (2015) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; mouse
In order to investigate junctional intercellular communication, mechanotransduction through cytoskeletal organization, and the hippo-YAP pathway in cardiac damage caused by direct exposure to ethanol, BD Biosciences CDH2 antibody (BD Biosciences, 610920) was used in western blot on mouse samples . PLoS ONE (2015) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunohistochemistry - paraffin section; mouse; 1:200; fig 6
BD Biosciences CDH2 antibody (BD Biosciences, 610920) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 6). Cell Death Dis (2015) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunohistochemistry; mouse; 1:100; fig 4
In order to determine tissue specific functions of DLL1 or DLL4 using transgenic mice, BD Biosciences CDH2 antibody (BD Transduction Lab, 610920) was used in immunohistochemistry on mouse samples at 1:100 (fig 4). PLoS Genet (2015) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunohistochemistry; human; loading ...; fig 2c
  • western blot; human; 1:1000; loading ...; fig 6b
BD Biosciences CDH2 antibody (BD Bioscience, 610920) was used in immunohistochemistry on human samples (fig 2c) and in western blot on human samples at 1:1000 (fig 6b). PLoS ONE (2015) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; human; 1:500; fig 3
BD Biosciences CDH2 antibody (BD Biosciences, 32/N-Cadherin) was used in western blot on human samples at 1:500 (fig 3). PLoS ONE (2015) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; human; fig 4d
In order to study how pre-transformation MTH1 levels in immortalized cells influence HRASV12-induced oncogenic transformation, BD Biosciences CDH2 antibody (BD Transduction laboratories, 610920) was used in western blot on human samples (fig 4d). Oncotarget (2015) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; human; fig 3b
BD Biosciences CDH2 antibody (BD, 610920) was used in western blot on human samples (fig 3b). Breast Cancer Res (2015) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunohistochemistry; mouse; loading ...; fig 5b
BD Biosciences CDH2 antibody (BD Biosciences, 610920) was used in immunohistochemistry on mouse samples (fig 5b). Sci Rep (2015) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunocytochemistry; human; 1:200
  • immunohistochemistry; human; 1:200
In order to investigate using liver-tumor organoids for in vitro modeling of liver metastasis, BD Biosciences CDH2 antibody (BD Biosciences, 610921) was used in immunocytochemistry on human samples at 1:200 and in immunohistochemistry on human samples at 1:200. Ann Biomed Eng (2015) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; mouse; 1:500-1:2000; fig s2
In order to describe and use a method to visualize newly synthesized proteins specifically, BD Biosciences CDH2 antibody (BD, 610921) was used in western blot on mouse samples at 1:500-1:2000 (fig s2). Nat Methods (2015) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; human; loading ...; fig 1a
BD Biosciences CDH2 antibody (BD Biosciences, 610920) was used in western blot on human samples (fig 1a). Oncotarget (2015) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; human; 1:5000
BD Biosciences CDH2 antibody (BD Transduction Laboratories, 610920) was used in western blot on human samples at 1:5000. J Biol Chem (2015) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; mouse; 1:500
In order to investigate the role of Cdh2 in the meiotic progression of Sertoli cells and fertility of mice, BD Biosciences CDH2 antibody (BD, 610921) was used in western blot on mouse samples at 1:500. Biol Reprod (2015) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; mouse
BD Biosciences CDH2 antibody (BD Bioscience, 32/N-Cadherin) was used in western blot on mouse samples . Neoplasia (2015) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; human; fig 4
In order to investigate the roles and mechanisms of the RSPO-LGR system in oncogenesis, BD Biosciences CDH2 antibody (BD Transduction Laboratories, 610920) was used in western blot on human samples (fig 4). Oncogene (2015) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunocytochemistry; human
In order to describe a method to rapidly generate neurons from human-induced pluripotent stem cells to elucidate the underlying regulatory programs, BD Biosciences CDH2 antibody (BD, 610920) was used in immunocytochemistry on human samples . Mol Syst Biol (2014) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; mouse; 1:2000
BD Biosciences CDH2 antibody (BD Transduction Laboratories, 610921) was used in western blot on mouse samples at 1:2000. PLoS ONE (2014) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; human; fig 4
In order to elucidate the role of COMMD1 in copper homeostasis, BD Biosciences CDH2 antibody (BD Biosciences, 610920) was used in western blot on human samples (fig 4). Mol Biol Cell (2015) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; human; 1:1000
In order to study the effect of epithelial cadherin expression on the induction of entosis, BD Biosciences CDH2 antibody (BD Biosciences, BD610920) was used in western blot on human samples at 1:1000. Cell Res (2014) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; human
BD Biosciences CDH2 antibody (BD Biosciences, 610920) was used in western blot on human samples . PLoS Genet (2014) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunocytochemistry; human; fig 1
  • western blot; human; fig 1
In order to analyze cancer cell plasticity autonomous stimulation by human NKG2D lymphocyte receptor coexpressed with its ligands on cancer cells, BD Biosciences CDH2 antibody (BD Transduction Laboratories, 32) was used in immunocytochemistry on human samples (fig 1) and in western blot on human samples (fig 1). PLoS ONE (2014) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; human; 1:1000; fig s1
In order to study juxtacrine signaling from macrophages and monocytes and a breast cancer stem cell niche, BD Biosciences CDH2 antibody (BD Biosciences, 610920) was used in western blot on human samples at 1:1000 (fig s1). Nat Cell Biol (2014) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; human
BD Biosciences CDH2 antibody (BD, 610920) was used in western blot on human samples . J Exp Clin Cancer Res (2014) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunohistochemistry; rat
In order to examine the progression of functional corticostriatal interactions, BD Biosciences CDH2 antibody (BD Transduction Labs, 610920) was used in immunohistochemistry on rat samples . J Comp Neurol (2015) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; human
In order to study the role of autoantibodies against the GABA(A) receptor to encephalitis, BD Biosciences CDH2 antibody (BD Biosciences, 610921) was used in western blot on human samples . J Neurosci (2014) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; human
BD Biosciences CDH2 antibody (BD Biosciences, 610921) was used in western blot on human samples . Int J Oncol (2014) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunohistochemistry; mouse; 1:400
  • western blot; mouse; 1:2000
In order to study the organization of adult hippocampal excitatory and inhibitory circuits and the role played by the N-cadherin/beta-catenin complex, BD Biosciences CDH2 antibody (BD Transduction Labs, 610921) was used in immunohistochemistry on mouse samples at 1:400 and in western blot on mouse samples at 1:2000. Hippocampus (2014) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; rat; 1:1000
BD Biosciences CDH2 antibody (BD Biosciences, 610920) was used in western blot on rat samples at 1:1000. PLoS ONE (2014) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunohistochemistry - frozen section; mouse; 1:100
  • western blot; mouse; 1:100
In order to study Notch signaling in the differentiation of neural progenitors, BD Biosciences CDH2 antibody (BD Transduction Laboratories, 610920) was used in immunohistochemistry - frozen section on mouse samples at 1:100 and in western blot on mouse samples at 1:100. Development (2014) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; mouse
BD Biosciences CDH2 antibody (BD Biosciences, 32) was used in western blot on mouse samples . PLoS ONE (2014) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; human
BD Biosciences CDH2 antibody (BD Biosciences, 610920) was used in western blot on human samples . Br J Cancer (2014) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunocytochemistry; human
  • western blot; human
In order to determine the role of desmoglein 2 in melanoma cells, BD Biosciences CDH2 antibody (BD Biosciences Pharmingen, clone 32) was used in immunocytochemistry on human samples and in western blot on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunohistochemistry - paraffin section; mouse; fig 2
  • western blot; mouse; fig 1
BD Biosciences CDH2 antibody (BD Transduction Labs, 610920) was used in immunohistochemistry - paraffin section on mouse samples (fig 2) and in western blot on mouse samples (fig 1). Biol Open (2014) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; human
BD Biosciences CDH2 antibody (BD Biosciences, 610920) was used in western blot on human samples . Exp Cell Res (2014) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; human
BD Biosciences CDH2 antibody (BD, 610920) was used in western blot on human samples . Oncogene (2014) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; human
In order to study the role of CREB in the mechanism by which neurotrypsin expression and agarin proteolysis is modulated by presenilins, BD Biosciences CDH2 antibody (BD, 610920) was used in western blot on human samples . J Biol Chem (2013) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; human
BD Biosciences CDH2 antibody (BD Pharmingen, 610920) was used in western blot on human samples . PLoS ONE (2013) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; mouse
BD Biosciences CDH2 antibody (BD Transduction Laboratories, 610920) was used in western blot on mouse samples . J Neurosci (2013) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunohistochemistry - frozen section; mouse
In order to study the role of endothelial-to-mesenchymal transition in the onset and progression of cerebral cavernous malformations, BD Biosciences CDH2 antibody (BD Biosciences, 610920) was used in immunohistochemistry - frozen section on mouse samples . Nature (2013) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunohistochemistry - frozen section; mouse
  • immunohistochemistry - paraffin section; human
BD Biosciences CDH2 antibody (BD Biosciences, 610921) was used in immunohistochemistry - frozen section on mouse samples and in immunohistochemistry - paraffin section on human samples . PLoS ONE (2013) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunocytochemistry; rat; 1:250
  • western blot; rat; 1:1000
In order to examine the role of UTP on N-cadherin expression in schwannoma cells, BD Biosciences CDH2 antibody (BD, 610921) was used in immunocytochemistry on rat samples at 1:250 and in western blot on rat samples at 1:1000. Purinergic Signal (2013) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; human
In order to study the role of TWIST1 activation by the MMSET histone methyltransferase in driving epithelial-to-mesenchymal transition and invasiveness in prostate cancer, BD Biosciences CDH2 antibody (BD Transduction Laboratories, 610920) was used in western blot on human samples . Oncogene (2013) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunohistochemistry - frozen section; mouse; 1:5000
BD Biosciences CDH2 antibody (BD Biosciences, 610921) was used in immunohistochemistry - frozen section on mouse samples at 1:5000. J Comp Neurol (2012) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunohistochemistry - frozen section; domestic sheep
  • western blot; domestic sheep
In order to study the role of desmosomes and adherens junctions in gap junction formation by cx43, BD Biosciences CDH2 antibody (BD, 610921) was used in immunohistochemistry - frozen section on domestic sheep samples and in western blot on domestic sheep samples . Heart Rhythm (2012) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; mouse; fig 4e
BD Biosciences CDH2 antibody (BD, 610921) was used in western blot on mouse samples (fig 4e). J Clin Invest (2011) ncbi
mouse monoclonal (32/N-Cadherin)
  • western blot; human; fig 5
In order to report that mesenchymal stromal cells support proliferation and self-renewal of hematopoietic stem and progenitor cells with primitive immunophenotype, BD Biosciences CDH2 antibody (BD, 32) was used in western blot on human samples (fig 5). J Cell Mol Med (2010) ncbi
mouse monoclonal (32/N-Cadherin)
  • immunohistochemistry - frozen section; mouse; 1:1000
In order to examine the involvement of catenin-cadherin mediated adhesion in the axonal projection of olfactory sensory neuron (OSN) axons, BD Biosciences CDH2 antibody (BD Biosciences, 610920) was used in immunohistochemistry - frozen section on mouse samples at 1:1000. J Comp Neurol (2006) ncbi
MilliporeSigma
mouse monoclonal (CH-19)
  • immunohistochemistry; rat; 1:500; fig 1d
MilliporeSigma CDH2 antibody (Sigma-Aldrich, C1821) was used in immunohistochemistry on rat samples at 1:500 (fig 1d). Sci Rep (2021) ncbi
Developmental Studies Hybridoma Bank
mouse monoclonal (6B3)
  • immunohistochemistry; chicken; 1:5; loading ...; fig 2a
In order to test if certain medicines alter Hirschsprung disease risk, Developmental Studies Hybridoma Bank CDH2 antibody (Developmental Studies Hybridoma Bank, 6B3) was used in immunohistochemistry on chicken samples at 1:5 (fig 2a). Dev Biol (2016) ncbi
Articles Reviewed
  1. Pan R, Yu Y, Zhu H, Zhang W, Qin Y, Ye L, et al. RSPO2 promotes progression of ovarian cancer through dual receptor-mediated FAK/Src signaling activation. iScience. 2022;25:105184 pubmed publisher
  2. Xie F, Zhou X, Su P, Li H, Tu Y, Du J, et al. Breast cancer cell-derived extracellular vesicles promote CD8+ T cell exhaustion via TGF-β type II receptor signaling. Nat Commun. 2022;13:4461 pubmed publisher
  3. Azarnia Tehran D, Kochlamazashvili G, Pampaloni N, Sposini S, Shergill J, Lehmann M, et al. Selective endocytosis of Ca2+-permeable AMPARs by the Alzheimer's disease risk factor CALM bidirectionally controls synaptic plasticity. Sci Adv. 2022;8:eabl5032 pubmed publisher
  4. Kimura Yoshida C, Mochida K, Kanno S, Matsuo I. USP39 is essential for mammalian epithelial morphogenesis through upregulation of planar cell polarity components. Commun Biol. 2022;5:378 pubmed publisher
  5. Castillo P, Aisagbonhi O, Saenz C, ElShamy W. Novel insights linking BRCA1-IRIS role in mammary gland development to formation of aggressive PABCs: the case for longer breastfeeding. Am J Cancer Res. 2022;12:396-426 pubmed
  6. Baeza V, Cifuentes M, Martinez F, Ramírez E, Nualart F, Ferrada L, et al. IIIG9 inhibition in adult ependymal cells changes adherens junctions structure and induces cellular detachment. Sci Rep. 2021;11:18537 pubmed publisher
  7. Cho A, Jin Y, An Y, Kim J, Choi Y, Lee J, et al. Microfluidic device with brain extracellular matrix promotes structural and functional maturation of human brain organoids. Nat Commun. 2021;12:4730 pubmed publisher
  8. Lee S, Jung J, Lee Y, Kim S, Kim J, Kim B, et al. Targeting HSF1 as a Therapeutic Strategy for Multiple Mechanisms of EGFR Inhibitor Resistance in EGFR Mutant Non-Small-Cell Lung Cancer. Cancers (Basel). 2021;13: pubmed publisher
  9. Nasu M, Esumi S, Hatakeyama J, Tamamaki N, Shimamura K. Two-Phase Lineage Specification of Telencephalon Progenitors Generated From Mouse Embryonic Stem Cells. Front Cell Dev Biol. 2021;9:632381 pubmed publisher
  10. Chen X, Ma W, Yao Y, Zhang Q, Li J, Wu X, et al. Serum deprivation-response protein induces apoptosis in hepatocellular carcinoma through ASK1-JNK/p38 MAPK pathways. Cell Death Dis. 2021;12:425 pubmed publisher
  11. Oh T, Lee M, Lee Y, Kim G, Lee D, You J, et al. PGC1α Loss Promotes Lung Cancer Metastasis through Epithelial-Mesenchymal Transition. Cancers (Basel). 2021;13: pubmed publisher
  12. Kariya Y, Oyama M, Suzuki T, Kariya Y. αvβ3 Integrin induces partial EMT independent of TGF-β signaling. Commun Biol. 2021;4:490 pubmed publisher
  13. Morcom L, Gobius I, Marsh A, Suárez R, Lim J, Bridges C, et al. DCC regulates astroglial development essential for telencephalic morphogenesis and corpus callosum formation. elife. 2021;10: pubmed publisher
  14. Fayad R, Rojas M, Partisani M, Finetti P, Dib S, Abélanet S, et al. EFA6B regulates a stop signal for collective invasion in breast cancer. Nat Commun. 2021;12:2198 pubmed publisher
  15. Sugita J, Fujiu K, Nakayama Y, Matsubara T, Matsuda J, Oshima T, et al. Cardiac macrophages prevent sudden death during heart stress. Nat Commun. 2021;12:1910 pubmed publisher
  16. Sun Y, Jing J, Xu H, Xu L, Hu H, Tang C, et al. N-cadherin inhibitor creates a microenvironment that protect TILs from immune checkpoints and Treg cells. J Immunother Cancer. 2021;9: pubmed publisher
  17. Zhou H, Qin L, Jiang Q, Murray K, Zhang H, Li B, et al. Caveolae-mediated Tie2 signaling contributes to CCM pathogenesis in a brain endothelial cell-specific Pdcd10-deficient mouse model. Nat Commun. 2021;12:504 pubmed publisher
  18. Dilshat R, Fock V, Kenny C, Gerritsen I, Lasseur R, Travnickova J, et al. MITF reprograms the extracellular matrix and focal adhesion in melanoma. elife. 2021;10: pubmed publisher
  19. van Berkel A, Santos T, Shaweis H, van Weering J, Toonen R, Verhage M. Loss of MUNC18-1 leads to retrograde transport defects in neurons. J Neurochem. 2021;157:450-466 pubmed publisher
  20. Roth J, Muench K, Asokan A, Mallett V, Gai H, Verma Y, et al. 16p11.2 microdeletion imparts transcriptional alterations in human iPSC-derived models of early neural development. elife. 2020;9: pubmed publisher
  21. Christgen M, Bartels S, van Luttikhuizen J, Bublitz J, Rieger L, Christgen H, et al. E-cadherin to P-cadherin switching in lobular breast cancer with tubular elements. Mod Pathol. 2020;33:2483-2498 pubmed publisher
  22. Liang W, Gao R, Yang M, Wang X, Cheng K, Shi X, et al. MARCKSL1 promotes the proliferation, migration and invasion of lung adenocarcinoma cells. Oncol Lett. 2020;19:2272-2280 pubmed publisher
  23. Singh S, Adam M, Matkar P, Bugyei Twum A, Desjardins J, Chen H, et al. Endothelial-specific Loss of IFT88 Promotes Endothelial-to-Mesenchymal Transition and Exacerbates Bleomycin-induced Pulmonary Fibrosis. Sci Rep. 2020;10:4466 pubmed publisher
  24. Moon H, Hippenmeyer S, Luo L, Wynshaw Boris A. LIS1 determines cleavage plane positioning by regulating actomyosin-mediated cell membrane contractility. elife. 2020;9: pubmed publisher
  25. Kim K, Shin W, Kang M, Lee S, Kim D, Kang R, et al. Presynaptic PTPσ regulates postsynaptic NMDA receptor function through direct adhesion-independent mechanisms. elife. 2020;9: pubmed publisher
  26. Chen Z, Zhang J, Xue H, Qian M, Guo X, Gao X, et al. Nitidine Chloride Is a Potential Alternative Therapy for Glioma Through Inducing Endoplasmic Reticulum Stress and Alleviating Epithelial-Mesenchymal Transition. Integr Cancer Ther. 2020;19:1534735419900927 pubmed publisher
  27. Xiong G, Chen J, Zhang G, Wang S, Kawasaki K, Zhu J, et al. Hsp47 promotes cancer metastasis by enhancing collagen-dependent cancer cell-platelet interaction. Proc Natl Acad Sci U S A. 2020;117:3748-3758 pubmed publisher
  28. Li Q, Mao F, Zhou B, Huang Y, Zou Z, Dendekker A, et al. p53 Integrates Temporal WDR5 Inputs during Neuroectoderm and Mesoderm Differentiation of Mouse Embryonic Stem Cells. Cell Rep. 2020;30:465-480.e6 pubmed publisher
  29. Dos Santos Carvalho S, Moreau M, Hien Y, Garcia M, Aubailly N, Henderson D, et al. Vangl2 acts at the interface between actin and N-cadherin to modulate mammalian neuronal outgrowth. elife. 2020;9: pubmed publisher
  30. Piprek R, Kolasa M, Podkowa D, Kloc M, Kubiak J. N-Cadherin Is Critical for the Survival of Germ Cells, the Formation of Steroidogenic Cells, and the Architecture of Developing Mouse Gonads. Cells. 2019;8: pubmed publisher
  31. Hiepen C, Jatzlau J, Hildebrandt S, Kampfrath B, Goktas M, Murgai A, et al. BMPR2 acts as a gatekeeper to protect endothelial cells from increased TGFβ responses and altered cell mechanics. PLoS Biol. 2019;17:e3000557 pubmed publisher
  32. Matsumoto S, Yamamichi T, Shinzawa K, Kasahara Y, Nojima S, Kodama T, et al. GREB1 induced by Wnt signaling promotes development of hepatoblastoma by suppressing TGFβ signaling. Nat Commun. 2019;10:3882 pubmed publisher
  33. Roy A, Murphy R, Deng M, MacDonald J, Bammler T, Aldinger K, et al. PI3K-Yap activity drives cortical gyrification and hydrocephalus in mice. elife. 2019;8: pubmed publisher
  34. Slobodnyuk K, Radic N, Ivanova S, Lladó A, Trempolec N, Zorzano A, et al. Autophagy-induced senescence is regulated by p38α signaling. Cell Death Dis. 2019;10:376 pubmed publisher
  35. Lubbers E, Murphy N, Musa H, Huang C, Gupta R, Price M, et al. Defining new mechanistic roles for αII spectrin in cardiac function. J Biol Chem. 2019;294:9576-9591 pubmed publisher
  36. Kim E, Lisby A, Ma C, Lo N, Ehmer U, Hayer K, et al. Promotion of growth factor signaling as a critical function of β-catenin during HCC progression. Nat Commun. 2019;10:1909 pubmed publisher
  37. Novielli Kuntz N, Jelen M, Barr K, DeLalio L, Feng Q, Isakson B, et al. Ablation of both Cx40 and Panx1 results in similar cardiovascular phenotypes exhibited in Cx40 knockout mice. Biosci Rep. 2019;39: pubmed publisher
  38. Li Y, Merkel C, Zeng X, Heier J, Cantrell P, Sun M, et al. The N-cadherin interactome in primary cardiomyocytes as defined using quantitative proximity proteomics. J Cell Sci. 2019;132: pubmed publisher
  39. Lee C, Cheng Y, Chang C, Lin C, Chang J. Alpha-tubulin acetyltransferase/MEC-17 regulates cancer cell migration and invasion through epithelial-mesenchymal transition suppression and cell polarity disruption. Sci Rep. 2018;8:17477 pubmed publisher
  40. Eley L, Alqahtani A, MacGrogan D, Richardson R, Murphy L, Salguero Jimenez A, et al. A novel source of arterial valve cells linked to bicuspid aortic valve without raphe in mice. elife. 2018;7: pubmed publisher
  41. Hsu J, Xia W, Hsu Y, Chan L, Yu W, Cha J, et al. STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion. Nat Commun. 2018;9:1908 pubmed publisher
  42. Zheng C, Wang J, Lin M, Zhang P, Liu L, Lin J, et al. CDK5RAP3 suppresses Wnt/β-catenin signaling by inhibiting AKT phosphorylation in gastric cancer. J Exp Clin Cancer Res. 2018;37:59 pubmed publisher
  43. Zhao H, Klausen C, Li Y, Zhu H, Wang Y, Leung P. Bone morphogenetic protein 2 promotes human trophoblast cell invasion by upregulating N-cadherin via non-canonical SMAD2/3 signaling. Cell Death Dis. 2018;9:174 pubmed publisher
  44. Glaeser K, Urban M, Fenech E, Voloshanenko O, Kranz D, Lari F, et al. ERAD-dependent control of the Wnt secretory factor Evi. EMBO J. 2018;37: pubmed publisher
  45. Hamada N, Iwamoto I, Tabata H, Nagata K. MUNC18-1 gene abnormalities are involved in neurodevelopmental disorders through defective cortical architecture during brain development. Acta Neuropathol Commun. 2017;5:92 pubmed publisher
  46. Cottard F, Madi Berthélémy P, Erdmann E, Schaff Wendling F, Keime C, Ye T, et al. Dual effects of constitutively active androgen receptor and full-length androgen receptor for N-cadherin regulation in prostate cancer. Oncotarget. 2017;8:72008-72020 pubmed publisher
  47. Roberts S, Dun X, Doddrell R, Mindos T, Drake L, Onaitis M, et al. Sox2 expression in Schwann cells inhibits myelination in vivo and induces influx of macrophages to the nerve. Development. 2017;144:3114-3125 pubmed publisher
  48. Logan C, Rajakaruna S, Bowen C, Radice G, Robinson M, Menko A. N-cadherin regulates signaling mechanisms required for lens fiber cell elongation and lens morphogenesis. Dev Biol. 2017;428:118-134 pubmed publisher
  49. Liu S, Cheng C. Akt Signaling Is Sustained by a CD44 Splice Isoform-Mediated Positive Feedback Loop. Cancer Res. 2017;77:3791-3801 pubmed publisher
  50. Sai K, Wang S, Kaito A, Fujiwara T, Maruo T, Itoh Y, et al. Multiple roles of afadin in the ultrastructural morphogenesis of mouse hippocampal mossy fiber synapses. J Comp Neurol. 2017;525:2719-2734 pubmed publisher
  51. Yoon C, Cho S, Chang K, Park D, Ryeom S, Yoon S. Role of Rac1 Pathway in Epithelial-to-Mesenchymal Transition and Cancer Stem-like Cell Phenotypes in Gastric Adenocarcinoma. Mol Cancer Res. 2017;15:1106-1116 pubmed publisher
  52. Wu Y, Jhao Y, Cheng Y, Chen Y. 15-Deoxy-?12,14-prostaglandin J2 inhibits migration of human thyroid carcinoma cells by disrupting focal adhesion complex and adherens junction. Oncol Lett. 2017;13:2569-2576 pubmed publisher
  53. Li P, Wang Y, Mao X, Jiang Y, Liu J, Li J, et al. CRB3 downregulation confers breast cancer stem cell traits through TAZ/?-catenin. Oncogenesis. 2017;6:e322 pubmed publisher
  54. Shen C, Kuo Y, Chen C, Chen M, Cheng Y. MMP1 expression is activated by Slug and enhances multi-drug resistance (MDR) in breast cancer. PLoS ONE. 2017;12:e0174487 pubmed publisher
  55. Mindos T, Dun X, North K, Doddrell R, Schulz A, Edwards P, et al. Merlin controls the repair capacity of Schwann cells after injury by regulating Hippo/YAP activity. J Cell Biol. 2017;216:495-510 pubmed publisher
  56. Gemel J, Su Z, Gileles Hillel A, Khalyfa A, Gozal D, Beyer E. Intermittent hypoxia causes NOX2-dependent remodeling of atrial connexins. BMC Cell Biol. 2017;18:7 pubmed publisher
  57. Bershteyn M, Nowakowski T, Pollen A, Di Lullo E, Nene A, Wynshaw Boris A, et al. Human iPSC-Derived Cerebral Organoids Model Cellular Features of Lissencephaly and Reveal Prolonged Mitosis of Outer Radial Glia. Cell Stem Cell. 2017;20:435-449.e4 pubmed publisher
  58. Maltabe V, Barka E, Kontonika M, Florou D, Kouvara Pritsouli M, Roumpi M, et al. Isolation of an ES-Derived Cardiovascular Multipotent Cell Population Based on VE-Cadherin Promoter Activity. Stem Cells Int. 2016;2016:8305624 pubmed publisher
  59. Le Dour C, Macquart C, Sera F, Homma S, Bonne G, Morrow J, et al. Decreased WNT/?-catenin signalling contributes to the pathogenesis of dilated cardiomyopathy caused by mutations in the lamin a/C gene. Hum Mol Genet. 2017;26:333-343 pubmed publisher
  60. Yu J, Lei R, Zhuang X, Li X, Li G, Lev S, et al. MicroRNA-182 targets SMAD7 to potentiate TGF?-induced epithelial-mesenchymal transition and metastasis of cancer cells. Nat Commun. 2016;7:13884 pubmed publisher
  61. Van Itallie C, Tietgens A, Anderson J. Visualizing the dynamic coupling of claudin strands to the actin cytoskeleton through ZO-1. Mol Biol Cell. 2017;28:524-534 pubmed publisher
  62. Ma H, Wang L, Liu J, Qian L. Direct Cardiac Reprogramming as a Novel Therapeutic Strategy for Treatment of Myocardial Infarction. Methods Mol Biol. 2017;1521:69-88 pubmed
  63. Bosch P, Fuller L, Sleeth C, Weiner J. Akirin2 is essential for the formation of the cerebral cortex. Neural Dev. 2016;11:21 pubmed
  64. Gilbert J, Man H. The X-Linked Autism Protein KIAA2022/KIDLIA Regulates Neurite Outgrowth via N-Cadherin and ?-Catenin Signaling. Eneuro. 2016;3: pubmed
  65. Gao Y, Mruk D, Chen H, Lui W, Lee W, Cheng C. Regulation of the blood-testis barrier by a local axis in the testis: role of laminin ?2 in the basement membrane. FASEB J. 2017;31:584-597 pubmed publisher
  66. Lian G, Dettenhofer M, Lu J, Downing M, Chenn A, Wong T, et al. Filamin A- and formin 2-dependent endocytosis regulates proliferation via the canonical Wnt pathway. Development. 2016;143:4509-4520 pubmed
  67. Polusani S, Kalmykov E, Chandrasekhar A, Zucker S, Nicholson B. Cell coupling mediated by connexin 26 selectively contributes to reduced adhesivity and increased migration. J Cell Sci. 2016;129:4399-4410 pubmed
  68. Lobato Álvarez J, Roldán M, López Murillo T, González Ramírez R, Bonilla Delgado J, Shoshani L. The Apical Localization of Na+, K+-ATPase in Cultured Human Retinal Pigment Epithelial Cells Depends on Expression of the ?2 Subunit. Front Physiol. 2016;7:450 pubmed
  69. Che D, Zhou T, Lan Y, Xie J, Gong H, Li C, et al. High glucose-induced epithelial-mesenchymal transition contributes to the upregulation of fibrogenic factors in retinal pigment epithelial cells. Int J Mol Med. 2016;38:1815-1822 pubmed publisher
  70. Takeuchi S, Iwama S, Takagi H, Kiyota A, Nakashima K, Izumida H, et al. Tomosyn Negatively Regulates Arginine Vasopressin Secretion in Embryonic Stem Cell-Derived Neurons. PLoS ONE. 2016;11:e0164544 pubmed publisher
  71. Shenoy A, Jin Y, Luo H, Tang M, Pampo C, Shao R, et al. Epithelial-to-mesenchymal transition confers pericyte properties on cancer cells. J Clin Invest. 2016;126:4174-4186 pubmed publisher
  72. Mai H, Xu X, Mei G, Hong T, Huang J, Wang T, et al. The interplay between HPIP and casein kinase 1? promotes renal cell carcinoma growth and metastasis via activation of mTOR pathway. Oncogenesis. 2016;5:e260 pubmed publisher
  73. Dubail J, Vasudevan D, Wang L, Earp S, Jenkins M, Haltiwanger R, et al. Impaired ADAMTS9 secretion: A potential mechanism for eye defects in Peters Plus Syndrome. Sci Rep. 2016;6:33974 pubmed publisher
  74. Matos M, Lapyckyj L, Rosso M, Besso M, Mencucci M, Briggiler C, et al. Identification of a Novel Human E-Cadherin Splice Variant and Assessment of Its Effects Upon EMT-Related Events. J Cell Physiol. 2017;232:1368-1386 pubmed publisher
  75. Lee E, Wang J, Yumoto K, Jung Y, Cackowski F, Decker A, et al. DNMT1 Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cells, Which Promotes Prostate Cancer Metastasis. Neoplasia. 2016;18:553-66 pubmed publisher
  76. Kim M, Jeong J, Seo J, Kim H, Kim S, Jin W. Dysregulated JAK2 expression by TrkC promotes metastasis potential, and EMT program of metastatic breast cancer. Sci Rep. 2016;6:33899 pubmed publisher
  77. Vardaki I, Ceder S, Rutishauser D, Baltatzis G, Foukakis T, Panaretakis T. Periostin is identified as a putative metastatic marker in breast cancer-derived exosomes. Oncotarget. 2016;7:74966-74978 pubmed publisher
  78. Li N, Lee W, Cheng C. Overexpression of plastin 3 in Sertoli cells disrupts actin microfilament bundle homeostasis and perturbs the tight junction barrier. Spermatogenesis. 2016;6:e1206353 pubmed publisher
  79. Matkar P, Singh K, Rudenko D, Kim Y, Kuliszewski M, Prud homme G, et al. Novel regulatory role of neuropilin-1 in endothelial-to-mesenchymal transition and fibrosis in pancreatic ductal adenocarcinoma. Oncotarget. 2016;7:69489-69506 pubmed publisher
  80. Szewczyk L, Brozko N, Nagalski A, Röckle I, Werneburg S, Hildebrandt H, et al. ST8SIA2 promotes oligodendrocyte differentiation and the integrity of myelin and axons. Glia. 2017;65:34-49 pubmed publisher
  81. Busse B, Bezrukov L, Blank P, Zimmerberg J. Resin embedded multicycle imaging (REMI): a tool to evaluate protein domains. Sci Rep. 2016;6:30284 pubmed publisher
  82. Kim R, Kaushik N, Suh Y, Yoo K, Cui Y, Kim M, et al. Radiation driven epithelial-mesenchymal transition is mediated by Notch signaling in breast cancer. Oncotarget. 2016;7:53430-53442 pubmed publisher
  83. Ku T, Swaney J, Park J, Albanese A, Murray E, Cho J, et al. Multiplexed and scalable super-resolution imaging of three-dimensional protein localization in size-adjustable tissues. Nat Biotechnol. 2016;34:973-81 pubmed publisher
  84. Li N, Mruk D, Chen H, Wong C, Lee W, Cheng C. Rescue of perfluorooctanesulfonate (PFOS)-mediated Sertoli cell injury by overexpression of gap junction protein connexin 43. Sci Rep. 2016;6:29667 pubmed publisher
  85. Pailler E, Oulhen M, Billiot F, Galland A, Auger N, Faugeroux V, et al. Method for semi-automated microscopy of filtration-enriched circulating tumor cells. BMC Cancer. 2016;16:477 pubmed publisher
  86. Dorland Y, Malinova T, van Stalborch A, Grieve A, van Geemen D, Jansen N, et al. The F-BAR protein pacsin2 inhibits asymmetric VE-cadherin internalization from tensile adherens junctions. Nat Commun. 2016;7:12210 pubmed publisher
  87. Cox A, Barrandon O, Cai E, Rios J, Chavez J, Bonnyman C, et al. Resolving Discrepant Findings on ANGPTL8 in ?-Cell Proliferation: A Collaborative Approach to Resolving the Betatrophin Controversy. PLoS ONE. 2016;11:e0159276 pubmed publisher
  88. Grassi M, Palma C, Thomé C, Lanfredi G, Poersch A, Faça V. Proteomic analysis of ovarian cancer cells during epithelial-mesenchymal transition (EMT) induced by epidermal growth factor (EGF) reveals mechanisms of cell cycle control. J Proteomics. 2017;151:2-11 pubmed publisher
  89. Gao Y, Lui W, Lee W, Cheng C. Polarity protein Crumbs homolog-3 (CRB3) regulates ectoplasmic specialization dynamics through its action on F-actin organization in Sertoli cells. Sci Rep. 2016;6:28589 pubmed publisher
  90. Folmsbee S, Wilcox D, Tyberghein K, De Bleser P, Tourtellotte W, van Hengel J, et al. ?T-catenin in restricted brain cell types and its potential connection to autism. J Mol Psychiatry. 2016;4:2 pubmed publisher
  91. Qi Y, Yu J, Han W, Fan X, Qian H, Wei H, et al. A splicing isoform of TEAD4 attenuates the Hippo-YAP signalling to inhibit tumour proliferation. Nat Commun. 2016;7:ncomms11840 pubmed publisher
  92. De Cian M, Pauper E, Bandiera R, Vidal V, Sacco S, Gregoire E, et al. Amplification of R-spondin1 signaling induces granulosa cell fate defects and cancers in mouse adult ovary. Oncogene. 2017;36:208-218 pubmed publisher
  93. Zhang H, Prado K, Zhang K, Peek E, Lee J, Wang X, et al. Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance. Clin Cancer Res. 2016;22:5349-5361 pubmed
  94. García Bea A, Walker M, Hyde T, Kleinman J, Harrison P, Lane T. Metabotropic glutamate receptor 3 (mGlu3; mGluR3; GRM3) in schizophrenia: Antibody characterisation and a semi-quantitative western blot study. Schizophr Res. 2016;177:18-27 pubmed publisher
  95. Wen M, Wang J, Chiu Y, Wang M, Lee S, Tai C. N-Cadherin Regulates Cell Migration Through a Rab5-Dependent Temporal Control of Macropinocytosis. Traffic. 2016;17:769-85 pubmed publisher
  96. Chen H, Mruk D, Lee W, Cheng C. Planar Cell Polarity (PCP) Protein Vangl2 Regulates Ectoplasmic Specialization Dynamics via Its Effects on Actin Microfilaments in the Testes of Male Rats. Endocrinology. 2016;157:2140-59 pubmed publisher
  97. Chang T, Chen C, Wu Y, Liu J, Kuo Y, Lee K, et al. Inflammation Promotes Expression of Stemness-Related Properties in HBV-Related Hepatocellular Carcinoma. PLoS ONE. 2016;11:e0149897 pubmed publisher
  98. Lee S, Shatadal S, Griep A. Dlg-1 Interacts With and Regulates the Activities of Fibroblast Growth Factor Receptors and EphA2 in the Mouse Lens. Invest Ophthalmol Vis Sci. 2016;57:707-18 pubmed publisher
  99. Jackson S, Olufs Z, Tran K, Zaidan N, Sridharan R. Alternative Routes to Induced Pluripotent Stem Cells Revealed by Reprogramming of the Neural Lineage. Stem Cell Reports. 2016;6:302-11 pubmed publisher
  100. Skardal A, Devarasetty M, Forsythe S, Atala A, Soker S. A reductionist metastasis-on-a-chip platform for in vitro tumor progression modeling and drug screening. Biotechnol Bioeng. 2016;113:2020-32 pubmed publisher
  101. Chojnacka K, Bilinska B, Mruk D. Interleukin 1alpha-induced disruption of the Sertoli cell cytoskeleton affects gap junctional communication. Cell Signal. 2016;28:469-480 pubmed publisher
  102. Wang X, Jung Y, Jun S, Lee S, Wang W, Schneider A, et al. PAF-Wnt signaling-induced cell plasticity is required for maintenance of breast cancer cell stemness. Nat Commun. 2016;7:10633 pubmed publisher
  103. Bertoldo M, Guibert E, Faure M, Guillou F, Ramé C, Nadal Desbarats L, et al. Specific deletion of AMP-activated protein kinase (α1AMPK) in mouse Sertoli cells modifies germ cell quality. Mol Cell Endocrinol. 2016;423:96-112 pubmed publisher
  104. Little E, Camp E, Wang C, Watson P, Watson D, Cole D. The CaSm (LSm1) oncogene promotes transformation, chemoresistance and metastasis of pancreatic cancer cells. Oncogenesis. 2016;5:e182 pubmed publisher
  105. Li N, Mruk D, Mok K, Li M, Wong C, Lee W, et al. Connexin 43 reboots meiosis and reseals blood-testis barrier following toxicant-mediated aspermatogenesis and barrier disruption. FASEB J. 2016;30:1436-52 pubmed publisher
  106. Wang G, Yu Y, Sun C, Liu T, Liang T, Zhan L, et al. STAT3 selectively interacts with Smad3 to antagonize TGF-β signalling. Oncogene. 2016;35:4388-98 pubmed publisher
  107. Bartscht T, Rosien B, Rades D, Kaufmann R, Biersack H, Lehnert H, et al. Dasatinib blocks transcriptional and promigratory responses to transforming growth factor-beta in pancreatic adenocarcinoma cells through inhibition of Smad signalling: implications for in vivo mode of action. Mol Cancer. 2015;14:199 pubmed publisher
  108. Lyon C, Wadey K, George S. Soluble N-cadherin: A novel inhibitor of VSMC proliferation and intimal thickening. Vascul Pharmacol. 2016;78:53-62 pubmed publisher
  109. Schill E, Lake J, Tusheva O, Nagy N, Bery S, Foster L, et al. Ibuprofen slows migration and inhibits bowel colonization by enteric nervous system precursors in zebrafish, chick and mouse. Dev Biol. 2016;409:473-88 pubmed publisher
  110. Wang J, Lu R, Yang J, Li H, He Z, Jing N, et al. TRPC6 specifically interacts with APP to inhibit its cleavage by γ-secretase and reduce Aβ production. Nat Commun. 2015;6:8876 pubmed publisher
  111. Fridriksdottir A, Kim J, Villadsen R, Klitgaard M, Hopkinson B, Petersen O, et al. Propagation of oestrogen receptor-positive and oestrogen-responsive normal human breast cells in culture. Nat Commun. 2015;6:8786 pubmed publisher
  112. Bhate A, Parker D, Bebee T, Ahn J, Arif W, Rashan E, et al. ESRP2 controls an adult splicing programme in hepatocytes to support postnatal liver maturation. Nat Commun. 2015;6:8768 pubmed publisher
  113. Koudelkova P, Weber G, Mikulits W. Liver Sinusoidal Endothelial Cells Escape Senescence by Loss of p19ARF. PLoS ONE. 2015;10:e0142134 pubmed publisher
  114. McCart Reed A, Kutasovic J, Vargas A, Jayanthan J, Al Murrani A, Reid L, et al. An epithelial to mesenchymal transition programme does not usually drive the phenotype of invasive lobular carcinomas. J Pathol. 2016;238:489-94 pubmed publisher
  115. Burns J, Kelly M, Hoa M, Morell R, Kelley M. Single-cell RNA-Seq resolves cellular complexity in sensory organs from the neonatal inner ear. Nat Commun. 2015;6:8557 pubmed publisher
  116. Nassal M, Werdich A, Wan X, Hoshi M, Deschênes I, Rosenbaum D, et al. Phosphorylation at Connexin43 Serine-368 Is Necessary for Myocardial Conduction During Metabolic Stress. J Cardiovasc Electrophysiol. 2016;27:110-9 pubmed publisher
  117. Arya P, Rainey M, Bhattacharyya S, Mohapatra B, George M, Kuracha M, et al. The endocytic recycling regulatory protein EHD1 Is required for ocular lens development. Dev Biol. 2015;408:41-55 pubmed publisher
  118. Martínez Revollar G, Garay E, Martín Tapia D, Nava P, Huerta M, Lopez Bayghen E, et al. Heterogeneity between triple negative breast cancer cells due to differential activation of Wnt and PI3K/AKT pathways. Exp Cell Res. 2015;339:67-80 pubmed publisher
  119. Marchi S, Corricelli M, Trapani E, Bravi L, Pittaro A, Delle Monache S, et al. Defective autophagy is a key feature of cerebral cavernous malformations. EMBO Mol Med. 2015;7:1403-17 pubmed publisher
  120. Basheer W, Harris B, Mentrup H, Abreha M, Thames E, Lea J, et al. Cardiomyocyte-specific overexpression of the ubiquitin ligase Wwp1 contributes to reduction in Connexin 43 and arrhythmogenesis. J Mol Cell Cardiol. 2015;88:1-13 pubmed publisher
  121. Poitelon Y, Bogni S, Matafora V, Della Flora Nunes G, Hurley E, Ghidinelli M, et al. Spatial mapping of juxtacrine axo-glial interactions identifies novel molecules in peripheral myelination. Nat Commun. 2015;6:8303 pubmed publisher
  122. Brigidi G, Santyr B, Shimell J, Jovellar B, Bamji S. Activity-regulated trafficking of the palmitoyl-acyl transferase DHHC5. Nat Commun. 2015;6:8200 pubmed publisher
  123. Noritake K, Aki T, Funakoshi T, Unuma K, Uemura K. Direct Exposure to Ethanol Disrupts Junctional Cell-Cell Contact and Hippo-YAP Signaling in HL-1 Murine Atrial Cardiomyocytes. PLoS ONE. 2015;10:e0136952 pubmed publisher
  124. Russell R, Perkhofer L, Liebau S, Lin Q, Lechel A, Feld F, et al. Loss of ATM accelerates pancreatic cancer formation and epithelial-mesenchymal transition. Nat Commun. 2015;6:7677 pubmed publisher
  125. Xu J, Wan P, Wang M, Zhang J, Gao X, Hu B, et al. AIP1-mediated actin disassembly is required for postnatal germ cell migration and spermatogonial stem cell niche establishment. Cell Death Dis. 2015;6:e1818 pubmed publisher
  126. Preuße K, Tveriakhina L, Schuster Gossler K, Gaspar C, Rosa A, Henrique D, et al. Context-Dependent Functional Divergence of the Notch Ligands DLL1 and DLL4 In Vivo. PLoS Genet. 2015;11:e1005328 pubmed publisher
  127. Lee Y, Han M, Baek S, Kim S, Oh S. MED30 Regulates the Proliferation and Motility of Gastric Cancer Cells. PLoS ONE. 2015;10:e0130826 pubmed publisher
  128. Rode K, Sieme H, Richterich P, Brehm R. Characterization of the equine blood-testis barrier during tubular development in normal and cryptorchid stallions. Theriogenology. 2015;84:763-72 pubmed publisher
  129. Li N, Mruk D, Wong C, Lee W, Han D, Cheng C. Actin-bundling protein plastin 3 is a regulator of ectoplasmic specialization dynamics during spermatogenesis in the rat testis. FASEB J. 2015;29:3788-805 pubmed publisher
  130. Zhang W, Gu Y, Sun Q, Siegel D, Tolias P, Yang Z, et al. Ex Vivo Maintenance of Primary Human Multiple Myeloma Cells through the Optimization of the Osteoblastic Niche. PLoS ONE. 2015;10:e0125995 pubmed publisher
  131. Liu S, Tetzlaff M, Wang T, Yang R, Xie L, Zhang G, et al. miR-200c/Bmi1 axis and epithelial-mesenchymal transition contribute to acquired resistance to BRAF inhibitor treatment. Pigment Cell Melanoma Res. 2015;28:431-41 pubmed publisher
  132. Giribaldi M, Muñoz A, Halvorsen K, Patel A, Rai P. MTH1 expression is required for effective transformation by oncogenic HRAS. Oncotarget. 2015;6:11519-29 pubmed
  133. ORELLANA R, Kato S, Erices R, Bravo M, Gonzalez P, Oliva B, et al. Platelets enhance tissue factor protein and metastasis initiating cell markers, and act as chemoattractants increasing the migration of ovarian cancer cells. BMC Cancer. 2015;15:290 pubmed publisher
  134. Zarzycka M, Chojnacka K, Mruk D, Górowska E, Hejmej A, Kotula Balak M, et al. Flutamide alters the distribution of c-Src and affects the N-cadherin-β-catenin complex in the seminiferous epithelium of adult rat. Andrology. 2015;3:569-81 pubmed publisher
  135. Li Y, Drabsch Y, Pujuguet P, Ren J, van Laar T, Zhang L, et al. Genetic depletion and pharmacological targeting of αv integrin in breast cancer cells impairs metastasis in zebrafish and mouse xenograft models. Breast Cancer Res. 2015;17:28 pubmed publisher
  136. Yarilin D, Xu K, Turkekul M, Fan N, Romin Y, Fijisawa S, et al. Machine-based method for multiplex in situ molecular characterization of tissues by immunofluorescence detection. Sci Rep. 2015;5:9534 pubmed publisher
  137. Skardal A, Devarasetty M, Rodman C, Atala A, Soker S. Liver-Tumor Hybrid Organoids for Modeling Tumor Growth and Drug Response In Vitro. Ann Biomed Eng. 2015;43:2361-73 pubmed publisher
  138. Tom Dieck S, Kochen L, Hanus C, Heumüller M, Bartnik I, Nassim Assir B, et al. Direct visualization of newly synthesized target proteins in situ. Nat Methods. 2015;12:411-4 pubmed publisher
  139. Qiao Y, Shiue C, Zhu J, Zhuang T, Jonsson P, Wright A, et al. AP-1-mediated chromatin looping regulates ZEB2 transcription: new insights into TNFα-induced epithelial-mesenchymal transition in triple-negative breast cancer. Oncotarget. 2015;6:7804-14 pubmed
  140. Tennakoon A, Izawa T, Wijesundera K, Katou Ichikawa C, Tanaka M, Golbar H, et al. Analysis of glial fibrillary acidic protein (GFAP)-expressing ductular cells in a rat liver cirrhosis model induced by repeated injections of thioacetamide (TAA). Exp Mol Pathol. 2015;98:476-85 pubmed publisher
  141. Kageyama T, Hayashi R, Hara S, Yoshikawa K, Ishikawa Y, Yamato M, et al. Spontaneous acquisition of infinite proliferative capacity by a rabbit corneal endothelial cell line with maintenance of phenotypic and physiological characteristics. J Tissue Eng Regen Med. 2017;11:1057-1064 pubmed publisher
  142. Yuan L, Seong E, Beuscher J, Arikkath J. δ-Catenin Regulates Spine Architecture via Cadherin and PDZ-dependent Interactions. J Biol Chem. 2015;290:10947-57 pubmed publisher
  143. Jiang X, Ma T, Zhang Y, Zhang H, Yin S, Zheng W, et al. Specific deletion of Cdh2 in Sertoli cells leads to altered meiotic progression and subfertility of mice. Biol Reprod. 2015;92:79 pubmed publisher
  144. Cai K, Wang Y, Smith E, Smedberg J, Yang D, Yang W, et al. Global deletion of Trp53 reverts ovarian tumor phenotype of the germ cell-deficient white spotting variant (Wv) mice. Neoplasia. 2015;17:89-100 pubmed publisher
  145. Zhang J, Upadhya D, Lu L, Reneker L. Fibroblast growth factor receptor 2 (FGFR2) is required for corneal epithelial cell proliferation and differentiation during embryonic development. PLoS ONE. 2015;10:e0117089 pubmed publisher
  146. Gong X, Yi J, Carmon K, Crumbley C, Xiong W, Thomas A, et al. Aberrant RSPO3-LGR4 signaling in Keap1-deficient lung adenocarcinomas promotes tumor aggressiveness. Oncogene. 2015;34:4692-701 pubmed publisher
  147. Davidson B, Holth A, Hellesylt E, Tan T, Huang R, Tropé C, et al. The clinical role of epithelial-mesenchymal transition and stem cell markers in advanced-stage ovarian serous carcinoma effusions. Hum Pathol. 2015;46:1-8 pubmed publisher
  148. Busskamp V, Lewis N, Guye P, Ng A, Shipman S, Byrne S, et al. Rapid neurogenesis through transcriptional activation in human stem cells. Mol Syst Biol. 2014;10:760 pubmed publisher
  149. Tao W, Moore R, Smith E, Xu X. Hormonal induction and roles of Disabled-2 in lactation and involution. PLoS ONE. 2014;9:e110737 pubmed publisher
  150. Phillips Krawczak C, Singla A, Starokadomskyy P, Deng Z, Osborne D, Li H, et al. COMMD1 is linked to the WASH complex and regulates endosomal trafficking of the copper transporter ATP7A. Mol Biol Cell. 2015;26:91-103 pubmed publisher
  151. Sun Q, Cibas E, Huang H, Hodgson L, Overholtzer M. Induction of entosis by epithelial cadherin expression. Cell Res. 2014;24:1288-98 pubmed publisher
  152. Suh S, Yoo J, Cui R, Kaur B, Huebner K, Lee T, et al. FHIT suppresses epithelial-mesenchymal transition (EMT) and metastasis in lung cancer through modulation of microRNAs. PLoS Genet. 2014;10:e1004652 pubmed publisher
  153. Cai X, Dai Z, Reeves R, Caballero Benítez A, Duran K, Delrow J, et al. Autonomous stimulation of cancer cell plasticity by the human NKG2D lymphocyte receptor coexpressed with its ligands on cancer cells. PLoS ONE. 2014;9:e108942 pubmed publisher
  154. Lu H, Clauser K, Tam W, Fröse J, Ye X, Eaton E, et al. A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages. Nat Cell Biol. 2014;16:1105-17 pubmed publisher
  155. Sun Y, Hu L, Zheng H, Bagnoli M, Guo Y, Rupaimoole R, et al. MiR-506 inhibits multiple targets in the epithelial-to-mesenchymal transition network and is associated with good prognosis in epithelial ovarian cancer. J Pathol. 2015;235:25-36 pubmed publisher
  156. Mok K, Mruk D, Cheng C. rpS6 regulates blood-testis barrier dynamics through Akt-mediated effects on MMP-9. J Cell Sci. 2014;127:4870-82 pubmed publisher
  157. Ye T, Ip J, Fu A, Ip N. Cdk5-mediated phosphorylation of RapGEF2 controls neuronal migration in the developing cerebral cortex. Nat Commun. 2014;5:4826 pubmed publisher
  158. Li J, Liu J, Li P, Mao X, Li W, Yang J, et al. Loss of LKB1 disrupts breast epithelial cell polarity and promotes breast cancer metastasis and invasion. J Exp Clin Cancer Res. 2014;33:70 pubmed publisher
  159. Friedman L, Riemslagh F, Sullivan J, Mesias R, Williams F, Huntley G, et al. Cadherin-8 expression, synaptic localization, and molecular control of neuronal form in prefrontal corticostriatal circuits. J Comp Neurol. 2015;523:75-92 pubmed publisher
  160. Herrera A, Saade M, Menendez A, Marti E, Pons S. Sustained Wnt/?-catenin signalling causes neuroepithelial aberrations through the accumulation of aPKC at the apical pole. Nat Commun. 2014;5:4168 pubmed publisher
  161. Ohkawa T, Satake S, Yokoi N, Miyazaki Y, Ohshita T, Sobue G, et al. Identification and characterization of GABA(A) receptor autoantibodies in autoimmune encephalitis. J Neurosci. 2014;34:8151-63 pubmed publisher
  162. Kudo Sakamoto Y, Akazawa H, Ito K, Takano J, Yano M, Yabumoto C, et al. Calpain-dependent cleavage of N-cadherin is involved in the progression of post-myocardial infarction remodeling. J Biol Chem. 2014;289:19408-19 pubmed publisher
  163. Katanosaka Y, Iwasaki K, Ujihara Y, Takatsu S, Nishitsuji K, Kanagawa M, et al. TRPV2 is critical for the maintenance of cardiac structure and function in mice. Nat Commun. 2014;5:3932 pubmed publisher
  164. Jung S, Ohk J, Jeong D, Li C, Lee S, Duan J, et al. Distinct regulatory effect of the p34SEI-1 oncoprotein on cancer metastasis in HER2/neu-positive and -negative cells. Int J Oncol. 2014;45:189-96 pubmed publisher
  165. Nikitczuk J, Patil S, Matikainen Ankney B, Scarpa J, Shapiro M, Benson D, et al. N-cadherin regulates molecular organization of excitatory and inhibitory synaptic circuits in adult hippocampus in vivo. Hippocampus. 2014;24:943-962 pubmed publisher
  166. Gong K, Kung L, Magni G, Bhargava A, Jasmin L. Increased response to glutamate in small diameter dorsal root ganglion neurons after sciatic nerve injury. PLoS ONE. 2014;9:e95491 pubmed publisher
  167. Hatakeyama J, Wakamatsu Y, Nagafuchi A, Kageyama R, Shigemoto R, Shimamura K. Cadherin-based adhesions in the apical endfoot are required for active Notch signaling to control neurogenesis in vertebrates. Development. 2014;141:1671-82 pubmed publisher
  168. Sehgal L, Mukhopadhyay A, Rajan A, Khapare N, Sawant M, Vishal S, et al. 14-3-3?-Mediated transport of plakoglobin to the cell border is required for the initiation of desmosome assembly in vitro and in vivo. J Cell Sci. 2014;127:2174-88 pubmed publisher
  169. Toyoshima D, Mandai K, Maruo T, Supriyanto I, Togashi H, Inoue T, et al. Afadin regulates puncta adherentia junction formation and presynaptic differentiation in hippocampal neurons. PLoS ONE. 2014;9:e89763 pubmed publisher
  170. Yoshida T, Ozawa Y, Kimura T, Sato Y, Kuznetsov G, Xu S, et al. Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states. Br J Cancer. 2014;110:1497-505 pubmed publisher
  171. Peitsch W, Doerflinger Y, Fischer Colbrie R, Huck V, Bauer A, Utikal J, et al. Desmoglein 2 depletion leads to increased migration and upregulation of the chemoattractant secretoneurin in melanoma cells. PLoS ONE. 2014;9:e89491 pubmed publisher
  172. Brueggmann D, Templeman C, Starzinski Powitz A, Rao N, Gayther S, Lawrenson K. Novel three-dimensional in vitro models of ovarian endometriosis. J Ovarian Res. 2014;7:17 pubmed publisher
  173. Moore R, Tao W, Meng Y, Smith E, Xu X. Cell adhesion and sorting in embryoid bodies derived from N- or E-cadherin deficient murine embryonic stem cells. Biol Open. 2014;3:121-8 pubmed publisher
  174. Fantozzi A, Gruber D, Pisarsky L, Heck C, Kunita A, Yilmaz M, et al. VEGF-mediated angiogenesis links EMT-induced cancer stemness to tumor initiation. Cancer Res. 2014;74:1566-75 pubmed publisher
  175. Miura S, Hamada S, Masamune A, Satoh K, Shimosegawa T. CUB-domain containing protein 1 represses the epithelial phenotype of pancreatic cancer cells. Exp Cell Res. 2014;321:209-18 pubmed publisher
  176. Zaganjor E, Osborne J, Weil L, Díaz Martínez L, Gonzales J, Singel S, et al. Ras regulates kinesin 13 family members to control cell migration pathways in transformed human bronchial epithelial cells. Oncogene. 2014;33:5457-66 pubmed publisher
  177. Almenar Queralt A, Kim S, Benner C, Herrera C, Kang D, Garcia Bassets I, et al. Presenilins regulate neurotrypsin gene expression and neurotrypsin-dependent agrin cleavage via cyclic AMP response element-binding protein (CREB) modulation. J Biol Chem. 2013;288:35222-36 pubmed publisher
  178. Haisler W, Timm D, Gage J, Tseng H, Killian T, Souza G. Three-dimensional cell culturing by magnetic levitation. Nat Protoc. 2013;8:1940-9 pubmed publisher
  179. Kumar M, Allison D, Baranova N, Wamsley J, Katz A, Bekiranov S, et al. NF-?B regulates mesenchymal transition for the induction of non-small cell lung cancer initiating cells. PLoS ONE. 2013;8:e68597 pubmed publisher
  180. Prox J, Bernreuther C, Altmeppen H, Grendel J, Glatzel M, D Hooge R, et al. Postnatal disruption of the disintegrin/metalloproteinase ADAM10 in brain causes epileptic seizures, learning deficits, altered spine morphology, and defective synaptic functions. J Neurosci. 2013;33:12915-28, 12928a pubmed publisher
  181. Sjödahl G, Lövgren K, Lauss M, Patschan O, Gudjonsson S, Chebil G, et al. Toward a molecular pathologic classification of urothelial carcinoma. Am J Pathol. 2013;183:681-91 pubmed publisher
  182. Maddaluno L, Rudini N, Cuttano R, Bravi L, Giampietro C, Corada M, et al. EndMT contributes to the onset and progression of cerebral cavernous malformations. Nature. 2013;498:492-6 pubmed publisher
  183. BRUSES J. Cell surface localization of ?3?4 nicotinic acetylcholine receptors is regulated by N-cadherin homotypic binding and actomyosin contractility. PLoS ONE. 2013;8:e62435 pubmed publisher
  184. Sigurdsson V, Ingthorsson S, Hilmarsdottir B, Gustafsdottir S, Franzdóttir S, Arason A, et al. Expression and functional role of sprouty-2 in breast morphogenesis. PLoS ONE. 2013;8:e60798 pubmed publisher
  185. Qian X, Mruk D, Cheng C. Rai14 (retinoic acid induced protein 14) is involved in regulating f-actin dynamics at the ectoplasmic specialization in the rat testis*. PLoS ONE. 2013;8:e60656 pubmed publisher
  186. Lee J, Mhawech Fauceglia P, Lee N, Parsanian L, Lin Y, Gayther S, et al. A three-dimensional microenvironment alters protein expression and chemosensitivity of epithelial ovarian cancer cells in vitro. Lab Invest. 2013;93:528-42 pubmed publisher
  187. Rakha E, Teoh T, Lee A, Nolan C, Ellis I, Green A. Further evidence that E-cadherin is not a tumour suppressor gene in invasive ductal carcinoma of the breast: an immunohistochemical study. Histopathology. 2013;62:695-701 pubmed publisher
  188. Martiáñez T, Lamarca A, Casals N, Gella A. N-cadherin expression is regulated by UTP in schwannoma cells. Purinergic Signal. 2013;9:259-70 pubmed publisher
  189. Danielson L, Park D, Rotllan N, Chamorro Jorganes A, Guijarro M, Fernandez Hernando C, et al. Cardiovascular dysregulation of miR-17-92 causes a lethal hypertrophic cardiomyopathy and arrhythmogenesis. FASEB J. 2013;27:1460-7 pubmed publisher
  190. Wang Q, Lin J, Chan S, Lin J. The Xin repeat-containing protein, mXinβ, initiates the maturation of the intercalated discs during postnatal heart development. Dev Biol. 2013;374:264-80 pubmed publisher
  191. Tran M, Choi W, Wszolek M, Navai N, Lee I, Nitti G, et al. The p63 protein isoform ?Np63? inhibits epithelial-mesenchymal transition in human bladder cancer cells: role of MIR-205. J Biol Chem. 2013;288:3275-88 pubmed publisher
  192. Ezponda T, Popovic R, Shah M, Martinez Garcia E, Zheng Y, Min D, et al. The histone methyltransferase MMSET/WHSC1 activates TWIST1 to promote an epithelial-mesenchymal transition and invasive properties of prostate cancer. Oncogene. 2013;32:2882-90 pubmed publisher
  193. Tang E, Xiao X, Mruk D, Qian X, Mok K, Jenardhanan P, et al. Microtubule affinity-regulating kinase 4 (MARK4) is a component of the ectoplasmic specialization in the rat testis. Spermatogenesis. 2012;2:117-126 pubmed
  194. Swope D, Li J, Muller E, Radice G. Analysis of a Jup hypomorphic allele reveals a critical threshold for postnatal viability. Genesis. 2012;50:717-27 pubmed publisher
  195. Stoyianni A, Goussia A, Pentheroudakis G, Siozopoulou V, Ioachim E, Krikelis D, et al. Immunohistochemical study of the epithelial-mesenchymal transition phenotype in cancer of unknown primary: incidence, correlations and prognostic utility. Anticancer Res. 2012;32:1273-81 pubmed
  196. Mortillo S, Elste A, Ge Y, Patil S, Hsiao K, Huntley G, et al. Compensatory redistribution of neuroligins and N-cadherin following deletion of synaptic ?1-integrin. J Comp Neurol. 2012;520:2041-52 pubmed publisher
  197. Chkourko H, Guerrero Serna G, Lin X, Darwish N, Pohlmann J, Cook K, et al. Remodeling of mechanical junctions and of microtubule-associated proteins accompany cardiac connexin43 lateralization. Heart Rhythm. 2012;9:1133-1140.e6 pubmed publisher
  198. Swope D, Cheng L, Gao E, Li J, Radice G. Loss of cadherin-binding proteins ?-catenin and plakoglobin in the heart leads to gap junction remodeling and arrhythmogenesis. Mol Cell Biol. 2012;32:1056-67 pubmed publisher
  199. Schneider D, Wu M, Le T, Cho S, Brenner M, Blackburn M, et al. Cadherin-11 contributes to pulmonary fibrosis: potential role in TGF-? production and epithelial to mesenchymal transition. FASEB J. 2012;26:503-12 pubmed publisher
  200. Maddala R, Chauhan B, Walker C, Zheng Y, Robinson M, Lang R, et al. Rac1 GTPase-deficient mouse lens exhibits defects in shape, suture formation, fiber cell migration and survival. Dev Biol. 2011;360:30-43 pubmed publisher
  201. Saghizadeh M, Soleymani S, Harounian A, Bhakta B, Troyanovsky S, Brunken W, et al. Alterations of epithelial stem cell marker patterns in human diabetic corneas and effects of c-met gene therapy. Mol Vis. 2011;17:2177-90 pubmed
  202. Watanabe R, Hayashi R, Kimura Y, Tanaka Y, Kageyama T, Hara S, et al. A novel gelatin hydrogel carrier sheet for corneal endothelial transplantation. Tissue Eng Part A. 2011;17:2213-9 pubmed publisher
  203. Ferro F, Spelat R, Falini G, Gallelli A, D Aurizio F, Puppato E, et al. Adipose tissue-derived stem cell in vitro differentiation in a three-dimensional dental bud structure. Am J Pathol. 2011;178:2299-310 pubmed publisher
  204. Yang Y, Ahn Y, Gibbons D, Zang Y, Lin W, Thilaganathan N, et al. The Notch ligand Jagged2 promotes lung adenocarcinoma metastasis through a miR-200-dependent pathway in mice. J Clin Invest. 2011;121:1373-85 pubmed publisher
  205. Li J, Swope D, Raess N, Cheng L, Muller E, Radice G. Cardiac tissue-restricted deletion of plakoglobin results in progressive cardiomyopathy and activation of {beta}-catenin signaling. Mol Cell Biol. 2011;31:1134-44 pubmed publisher
  206. Liu M, Sakamaki T, Casimiro M, Willmarth N, Quong A, Ju X, et al. The canonical NF-kappaB pathway governs mammary tumorigenesis in transgenic mice and tumor stem cell expansion. Cancer Res. 2010;70:10464-73 pubmed publisher
  207. Palatinus J, O Quinn M, Barker R, Harris B, Jourdan J, Gourdie R. ZO-1 determines adherens and gap junction localization at intercalated disks. Am J Physiol Heart Circ Physiol. 2011;300:H583-94 pubmed publisher
  208. Schoenauer R, Emmert M, Felley A, Ehler E, Brokopp C, Weber B, et al. EH-myomesin splice isoform is a novel marker for dilated cardiomyopathy. Basic Res Cardiol. 2011;106:233-47 pubmed publisher
  209. Su L, Cheng C, Mruk D. Adjudin-mediated Sertoli-germ cell junction disassembly affects Sertoli cell barrier function in vitro and in vivo. Int J Biochem Cell Biol. 2010;42:1864-75 pubmed publisher
  210. Su L, Mruk D, Lee W, Cheng C. Differential effects of testosterone and TGF-?3 on endocytic vesicle-mediated protein trafficking events at the blood-testis barrier. Exp Cell Res. 2010;316:2945-60 pubmed publisher
  211. Flatmark K, Davidson B, Kristian A, Stavnes H, Førsund M, Reed W. Exploring the peritoneal surface malignancy phenotype--a pilot immunohistochemical study of human pseudomyxoma peritonei and derived animal models. Hum Pathol. 2010;41:1109-19 pubmed publisher
  212. Kaarteenaho R, Sormunen R, Paakko P. Variable expression of tenascin-C, osteopontin and fibronectin in inflammatory myofibroblastic tumour of the lung. APMIS. 2010;118:91-100 pubmed publisher
  213. D Eliseo D, Pisu P, Romano C, Tubaro A, De Nunzio C, Morrone S, et al. Granzyme B is expressed in urothelial carcinoma and promotes cancer cell invasion. Int J Cancer. 2010;127:1283-94 pubmed publisher
  214. Yiin J, Hu B, Jarzynka M, Feng H, Liu K, Wu J, et al. Slit2 inhibits glioma cell invasion in the brain by suppression of Cdc42 activity. Neuro Oncol. 2009;11:779-89 pubmed publisher
  215. Lapyckyj L, Castillo L, Matos M, Gabrielli N, Lüthy I, Vazquez Levin M. Expression analysis of epithelial cadherin and related proteins in IBH-6 and IBH-4 human breast cancer cell lines. J Cell Physiol. 2010;222:596-605 pubmed publisher
  216. Romeih M, Cakstina I, Zile M. Retinoic acid is a negative physiological regulator of N-cadherin during early avian heart morphogenesis. Dev Growth Differ. 2009;51:753-67 pubmed publisher
  217. Marín Briggiler C, Lapyckyj L, Gonzalez Echeverria M, Rawe V, Alvarez Sedó C, Vazquez Levin M. Neural cadherin is expressed in human gametes and participates in sperm-oocyte interaction events. Int J Androl. 2010;33:e228-39 pubmed publisher
  218. Hwang C, Song K, Kim C, Choi H, Guo X, Law P, et al. Epigenetic programming of mu-opioid receptor gene in mouse brain is regulated by MeCP2 and Brg1 chromatin remodelling factor. J Cell Mol Med. 2009;13:3591-615 pubmed publisher
  219. Walenda T, Bork S, Horn P, Wein F, Saffrich R, Diehlmann A, et al. Co-culture with mesenchymal stromal cells increases proliferation and maintenance of haematopoietic progenitor cells. J Cell Mol Med. 2010;14:337-50 pubmed publisher
  220. Marrs G, Theisen C, BRUSES J. N-cadherin modulates voltage activated calcium influx via RhoA, p120-catenin, and myosin-actin interaction. Mol Cell Neurosci. 2009;40:390-400 pubmed publisher
  221. Li Z, Zhou Z, Welch D, Donahue H. Expressing connexin 43 in breast cancer cells reduces their metastasis to lungs. Clin Exp Metastasis. 2008;25:893-901 pubmed publisher
  222. Mosnier J, Kandel C, Cazals Hatem D, Bou Hanna C, Gournay J, Jarry A, et al. N-cadherin serves as diagnostic biomarker in intrahepatic and perihilar cholangiocarcinomas. Mod Pathol. 2009;22:182-90 pubmed publisher
  223. Fondrevelle M, Kantelip B, Reiter R, Chopin D, Thiery J, Monnien F, et al. The expression of Twist has an impact on survival in human bladder cancer and is influenced by the smoking status. Urol Oncol. 2009;27:268-76 pubmed publisher
  224. Agarwal S, Lee D, Kiener H, Brenner M. Coexpression of two mesenchymal cadherins, cadherin 11 and N-cadherin, on murine fibroblast-like synoviocytes. Arthritis Rheum. 2008;58:1044-54 pubmed publisher
  225. Li J, Levin M, Xiong Y, Petrenko N, Patel V, Radice G. N-cadherin haploinsufficiency affects cardiac gap junctions and arrhythmic susceptibility. J Mol Cell Cardiol. 2008;44:597-606 pubmed publisher
  226. Lim S, Lim K, Giuliano R, Federoff H. Temporal and spatial localization of nectin-1 and l-afadin during synaptogenesis in hippocampal neurons. J Comp Neurol. 2008;507:1228-44 pubmed publisher
  227. Wu J, Yan H, Chen W, Chen W, Wang C, Chi Y, et al. JNK signaling pathway is required for bFGF-mediated surface cadherin downregulation on HUVEC. Exp Cell Res. 2008;314:421-9 pubmed publisher
  228. Braun A, Xu H, Hu F, Kocherlakota P, Siegel D, Chander P, et al. Paucity of pericytes in germinal matrix vasculature of premature infants. J Neurosci. 2007;27:12012-24 pubmed
  229. Zhang S, Liu Y, Huang G, Liu L. Aconitine alters connexin43 phosphorylation status and [Ca2+] oscillation patterns in cultured ventricular myocytes of neonatal rats. Toxicol In Vitro. 2007;21:1476-85 pubmed
  230. Hwang C, Song K, Kim C, Choi H, Guo X, Law P, et al. Evidence of endogenous mu opioid receptor regulation by epigenetic control of the promoters. Mol Cell Biol. 2007;27:4720-36 pubmed
  231. Wang C, Mruk D, Lee W, Cheng C. Coxsackie and adenovirus receptor (CAR) is a product of Sertoli and germ cells in rat testes which is localized at the Sertoli-Sertoli and Sertoli-germ cell interface. Exp Cell Res. 2007;313:1373-92 pubmed
  232. Sharma M, Henderson B. IQ-domain GTPase-activating protein 1 regulates beta-catenin at membrane ruffles and its role in macropinocytosis of N-cadherin and adenomatous polyposis coli. J Biol Chem. 2007;282:8545-56 pubmed
  233. Chang M, Boulden J, Sutanto Ward E, DuHadaway J, Soler A, Muller A, et al. Bin1 ablation in mammary gland delays tissue remodeling and drives cancer progression. Cancer Res. 2007;67:100-7 pubmed
  234. Warchol M. Characterization of supporting cell phenotype in the avian inner ear: implications for sensory regeneration. Hear Res. 2007;227:11-8 pubmed
  235. Akins M, Greer C. Axon behavior in the olfactory nerve reflects the involvement of catenin-cadherin mediated adhesion. J Comp Neurol. 2006;499:979-89 pubmed
  236. Blixt A, Landgren H, Johansson B, Carlsson P. Foxe3 is required for morphogenesis and differentiation of the anterior segment of the eye and is sensitive to Pax6 gene dosage. Dev Biol. 2007;302:218-29 pubmed
  237. Moreno Bueno G, Cubillo E, Sarrio D, Peinado H, Rodriguez Pinilla S, Villa S, et al. Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for Snail, Slug, and E47 factors in epithelial-mesenchymal transition. Cancer Res. 2006;66:9543-56 pubmed
  238. Lascombe I, Clairotte A, Fauconnet S, Bernardini S, Wallerand H, Kantelip B, et al. N-cadherin as a novel prognostic marker of progression in superficial urothelial tumors. Clin Cancer Res. 2006;12:2780-7 pubmed
  239. Liu Z, Xiao M, Balint K, Smalley K, Brafford P, Qiu R, et al. Notch1 signaling promotes primary melanoma progression by activating mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression. Cancer Res. 2006;66:4182-90 pubmed
  240. Sarkar O, Xia W, Mruk D. Adjudin-mediated junction restructuring in the seminiferous epithelium leads to displacement of soluble guanylate cyclase from adherens junctions. J Cell Physiol. 2006;208:175-87 pubmed
  241. Kim Y, Sauer C, Testa K, Wahl J, Svoboda R, Johnson K, et al. Modulating the strength of cadherin adhesion: evidence for a novel adhesion complex. J Cell Sci. 2005;118:3883-94 pubmed
  242. Sun X, Wei L, Liden J, Hui G, Dahlman Wright K, Hjerpe A, et al. Molecular characterization of tumour heterogeneity and malignant mesothelioma cell differentiation by gene profiling. J Pathol. 2005;207:91-101 pubmed
  243. Bassarova A, Torlakovic E, Sedloev T, Hristova S, Trifonov D, Nesland J. Simultaneous bilateral breast carcinoma: Histopathological characteristics and CD44/catenin-cadherin profile. Histol Histopathol. 2005;20:791-9 pubmed publisher
  244. Xia W, Cheng C. TGF-beta3 regulates anchoring junction dynamics in the seminiferous epithelium of the rat testis via the Ras/ERK signaling pathway: An in vivo study. Dev Biol. 2005;280:321-43 pubmed
  245. Xia W, Wong C, Lee N, Lee W, Cheng C. Disruption of Sertoli-germ cell adhesion function in the seminiferous epithelium of the rat testis can be limited to adherens junctions without affecting the blood-testis barrier integrity: an in vivo study using an androgen suppression model. J Cell Physiol. 2005;205:141-57 pubmed
  246. Knudsen K, Sauer C, Johnson K, Wheelock M. Effect of N-cadherin misexpression by the mammary epithelium in mice. J Cell Biochem. 2005;95:1093-107 pubmed
  247. Foty R, Steinberg M. The differential adhesion hypothesis: a direct evaluation. Dev Biol. 2005;278:255-63 pubmed
  248. Marques F, Fonsechi Carvasan G, de Angelo Andrade L, Bottcher Luiz F. Immunohistochemical patterns for alpha- and beta-catenin, E- and N-cadherin expression in ovarian epithelial tumors. Gynecol Oncol. 2004;94:16-24 pubmed
  249. Kapoor P, Saunders M, Li Z, Zhou Z, Sheaffer N, Kunze E, et al. Breast cancer metastatic potential: correlation with increased heterotypic gap junctional intercellular communication between breast cancer cells and osteoblastic cells. Int J Cancer. 2004;111:693-7 pubmed
  250. Bassarova A, Nesland J, Sedloev T, Danielsen H, Christova S. Pilomatrix carcinoma with lymph node metastases. J Cutan Pathol. 2004;31:330-5 pubmed
  251. Lee N, Mruk D, Conway A, Cheng C. Zyxin, axin, and Wiskott-Aldrich syndrome protein are adaptors that link the cadherin/catenin protein complex to the cytoskeleton at adherens junctions in the seminiferous epithelium of the rat testis. J Androl. 2004;25:200-15 pubmed
  252. Ng J, Han A, Edelson M, Rosenblum N. Oncoprotein profiles of primary peritoneal malignant mixed müllerian tumors. Int J Gynecol Cancer. 2003;13:870-4 pubmed
  253. Siu M, Cheng C. Interactions of proteases, protease inhibitors, and the beta1 integrin/laminin gamma3 protein complex in the regulation of ectoplasmic specialization dynamics in the rat testis. Biol Reprod. 2004;70:945-64 pubmed
  254. Ordonez N. Value of E-cadherin and N-cadherin immunostaining in the diagnosis of mesothelioma. Hum Pathol. 2003;34:749-55 pubmed
  255. Duguay D, Foty R, Steinberg M. Cadherin-mediated cell adhesion and tissue segregation: qualitative and quantitative determinants. Dev Biol. 2003;253:309-23 pubmed
  256. Luo Y, Radice G. Cadherin-mediated adhesion is essential for myofibril continuity across the plasma membrane but not for assembly of the contractile apparatus. J Cell Sci. 2003;116:1471-9 pubmed
  257. Lee N, Mruk D, Lee W, Cheng C. Is the cadherin/catenin complex a functional unit of cell-cell actin-based adherens junctions in the rat testis?. Biol Reprod. 2003;68:489-508 pubmed
  258. Rocha A, Soares P, Machado J, Máximo V, Fonseca E, Franssila K, et al. Mucoepidermoid carcinoma of the thyroid: a tumour histotype characterised by P-cadherin neoexpression and marked abnormalities of E-cadherin/catenins complex. Virchows Arch. 2002;440:498-504 pubmed
  259. Ferreira Cornwell M, Luo Y, Narula N, Lenox J, Lieberman M, Radice G. Remodeling the intercalated disc leads to cardiomyopathy in mice misexpressing cadherins in the heart. J Cell Sci. 2002;115:1623-34 pubmed
  260. Paredes J, Milanezi F, Viegas L, Amendoeira I, Schmitt F. P-cadherin expression is associated with high-grade ductal carcinoma in situ of the breast. Virchows Arch. 2002;440:16-21 pubmed
  261. Laskin W, Miettinen M. Epithelial-type and neural-type cadherin expression in malignant noncarcinomatous neoplasms with epithelioid features that involve the soft tissues. Arch Pathol Lab Med. 2002;126:425-31 pubmed
  262. Wheelock M, Soler A, Knudsen K. Cadherin junctions in mammary tumors. J Mammary Gland Biol Neoplasia. 2001;6:275-85 pubmed
  263. Rocha A, Soares P, Seruca R, Máximo V, Matias Guiu X, Cameselle Teijeiro J, et al. Abnormalities of the E-cadherin/catenin adhesion complex in classical papillary thyroid carcinoma and in its diffuse sclerosing variant. J Pathol. 2001;194:358-66 pubmed
  264. Gottardi C, Wong E, Gumbiner B. E-cadherin suppresses cellular transformation by inhibiting beta-catenin signaling in an adhesion-independent manner. J Cell Biol. 2001;153:1049-60 pubmed
  265. Li G, Satyamoorthy K, Herlyn M. N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells. Cancer Res. 2001;61:3819-25 pubmed
  266. Luo Y, Ferreira Cornwell M, Baldwin H, Kostetskii I, Lenox J, Lieberman M, et al. Rescuing the N-cadherin knockout by cardiac-specific expression of N- or E-cadherin. Development. 2001;128:459-69 pubmed
  267. Mahlapuu M, Ormestad M, Enerback S, Carlsson P. The forkhead transcription factor Foxf1 is required for differentiation of extra-embryonic and lateral plate mesoderm. Development. 2001;128:155-66 pubmed
  268. van Raamsdonk C, Tilghman S. Dosage requirement and allelic expression of PAX6 during lens placode formation. Development. 2000;127:5439-48 pubmed